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ABSTRACT
Quality of Life (QOL) amongst transplant patients has become an issue as a means to
optimize the use of scarce resources and improve outcome. The relationship between
QOL, medical compliance, psychosocial states and QOL is presented as follows:
Patient empowerment: Patient empowerment and compliance with medications in
patients who experienced late acute rejection, was assessed using the Long-term
Medication Behaviour Scale (LTMBS-scale). We demonstrated a relationship
between late acute rejection and low confidence in taking medication and items
relating to physical and psychological symptoms.
Effect of psychotherapeutic program on emotional states after kidney transplantation:
Recurring emotional states as recalled by patients during psychotherapy sessions (e.g.
loss of QOL) were analysed and used to formulate effective group and individual
psychotherapy intervention. The Beck Depression Inventory (BDI) was utilised as a
measure of change before, during and after treatment. There was significant
improvement in psychological states after therapy contemplated as follows, (i) fear of
rejection, (ii) feelings of paradoxical loss (iii) psychological integration of the
transplant.
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Randomised controlled study to determine the efficacy of individual or group
psychotherapy amongst kidney transplant patients: Analysis of group and individual
psychotherapy in recipients of kidney transplants versus control patients was
conducted. Improvement appeared to be more significant in the individual therapy
compared to group therapy (p= 0.01). In both the individual and group therapy arm,
lowering of scores was progressive and sustained (p=O.OI). However, individual
therapy resulted in the lowest BDI scores at the end of treatment period.
Coming to terms with the 'imagined past': After a successful transplant, patients may
present with feelings of paradoxical loss (e.g. grief or low mood). We propose that
paradoxical loss should be considered in terms of an imagined past (loss of life goals
which have never been actualised as a result of chronic illness). Feelings of loss
present an obstacle to a good QOL after transplantation as low mood may lead to
ambivalence and subsequently to non-compliance.
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INTRODUCTION
This context statement summarises the claim for which PhD equivalence is being
claimed for work undertaken at the University of Glasgow, UK, and Avera Mckennan
University Hospital, Sioux Falls, South Dakota, USA, as the Principal Investigator.
A standardised definition of QOL remains illusive along with the factors that
actually constitute QOL. However, it is fair to say that academics that have been
involved in the development of QOL have been concerned to evolve an instrument
that is essentially a standard verifiable measurement tool. Schipper, Clinch and
Olweny (1996) have arbitrarily divided QOL into the following components: physical
performance and occupational function, psychological state, social interaction and
somatic sensation. Whiting (2001) has succinctly defined QOL as the measurement
. and quantification of the patient's subjective perspective of various health-related
concepts. Whiting went on to identify three basic elements of QOL instruments;
health preferences, health values and utilities, however, in practice these are grouped
under the term 'utility measure'. Both definitions are particularly apt for a research
thesis concerned to determine the patient's experiences of kidney transplantation.
Defining QOL and continues to be an area of intense research, while a universally
accepted instrument to measure QOL remains elusive (Guggenmoos-Holzman,
Bloomfield, Brenner and Flick 1995). In defining QOL, there is also a conflict
between choosing criteria based on societal values versus criteria based on the values
of the individual and population groups and across different countries or across
different ethnic groups within the same country (Patrick and Bergner 1990). Attempts
are being made to create a culturally sensitive QOL instrument that may be applicable
to different ethnic groups and in different countries, which will capture subtle ethnic
and linguistic differences in QOL studies (World Health Organization QOL group
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1993). It must, however, be realised that some persons living in social isolation,
unemployment, poverty or adverse living conditions may still report a positive life
satisfaction. This probably reflects their accommodation to adverse conditions and
does not imply that they would not wish to improve their life circumstances should
the opportunity arise in the form of better medications, rehabilitation of job
opportunities. Occasionally, some patients when exposed to a positive intervention
may give decreased QOL from the baseline. This may suggest that the patients are
now more aware of the opportunities and are eager to improve their lives even more
(Lehman, Postrado and Rachuba 1993).
To measure QOL, the most widely used generic questionnaires are the
Sickness Impact Profile [SIP] (Bergner, Bobbit, Carter and Gilson 1981), Nottingham
Health Profile (Hunt, McKenna, McEwen and Papp 1981) and the SF-36 (36-item
Short Form Health Survey) [Ware Jr and Sherborne 1992], the latter instrument has
been condensed to SF-12, a measure validated in numerous disease states and in many
countries (Ware Jr and Sherborne 1992). The disease-specific questionnaires in
transplantation, which have been validated, are the Kidney Transplant Questionnaire
(Laupacis et al. 1996) and the End Stage Renal Disease Symptom Checklist [ESRD-
SC] (Franke et al. 1999). SF-36 is a global QOL instrument looking at eight scales -
physical function, physical role, pain, and perception of general health, vitality, social
function, emotional role and mental health. Other instruments in use are the disease-
specific QOL instrument such as the Karnofsky Index, Activities of Daily Living,
Brief Symptom Inventory (BSI) [Derogatis 1993] and Mini Mental State
Examination.
There is reported confusion between health-related quality of life (HQOL) and the
broader topic of QOL and the components of measurement (Bowling 1995; Levine
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1995; Albrecht and Devlieger, 1999). "Quality of Life is an evaluation of the
condition of the external environment in part by observing the impact on individuals,
while HQOL is an evaluation of the condition of the individual as influenced by his or
her own bodily state as well as external antecedent and intervening factors such as
medical care, health policy, and social settings and conditions" (Lerner and Levine
1994). In other words, QOL is a more general concept and includes various life issues
such as income, standard of living, work conditions, marriage, family and friends,
neighbourhood, system of government and even public safety. The term QOL is more
readily understood by the general public; "QOL" is used in every day conversation
and is the preferred term in transplant literature. HQOL on the other had is a more
restricted term, which is defined by Patrick and Erickson (1993) as "HQOL is the
value assigned to the duration of life as modified by the impairments, functional
states, perceptions, and social opportunities, that are influenced by disease, injury,
treatment or policy". Therefore, HQOL is more influenced by the physical health
status and the person's ability to perform the social roles in hislher life and his/her
satisfaction with these roles. Furthermore, HQOL is also dependent was is also
dependent upon a person's social environment such as his/her friends, confidants and
a supportive community environment to which he/she can tum for help and guidance
(Patrick and Erickson 1993).
A study of QOL is important as it measures the effect of treatment or
procedure on a person's 'goodness of life', a person's happiness and the ability to
function independently and to enjoy life (Parmet 2002). It has been speculated that the
definition of QOL may have been inspired by the World Health Organization's
constitution in 1948 that stated that health is not just the absence of disease, but "a
state of complete physical, mental and social well-being". Information obtained by
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QOL studies can be integrated into economic outcomes to evaluate the performance
of individual centres (Keown 2001). Transplant centres will be able to compare their
outcomes with other programs and to monitor quality and implement appropriate
changes, justifying the added administrative cost of this exercise. Data obtained from
QOL studies can also be used to compare different medications (Hilbrands, Hoitsma
and Koene 1995; Dew et al. 1997; Shield, McGrath and Goss 1997).
As there is a far greater demand for kidney transplants than the supply, it is
important that we measure the QOL after the transplant to ensure that the patients
benefit from a complex procedure and will comply with the rigorous demands of
follow-up and life-long anti-rejection therapy (Keown 2001; Matas et al. 2002a). The
need for such instruments has expanded in recent times because comparisons must be
made between smaller differences in the outcomes and the effect of treatment. More
importantly, there is a greater understanding and emphasis on the quality rather than
merely the quantity or length of life preserved by medical technology. Furthermore,
the development of QOL instruments has been facilitated by improved coding and
computerisation of medical records, better understanding of social-role functioning,
understanding of cultural and linguistic differences between races and peoples and the
widespread implementation of statistical methodology and Diagnosis Related Groups
(DRG) in hospital care.
There are only a few studies that have explored the link between QOL and
morbidity after kidney transplantation. German investigators used the BSI and a
German Social Support Questionnaire, SF-36, End-Stage Renal Disease Symptom
Checklist-Transplantation Module to two group of patients; Group A consisted of 80
patients treated by dialysis while on the waiting list for transplantation when
investigated at baseline and was followed after successful transplantation. Group B
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consisted of 222 patients investigated twice after successful kidney transplant. Group
A demonstrated a statistically significant increased satisfaction with social support
after kidney transplantation while group B patients reported a decrease. The
psychological distress at baseline predicted QOL at later time point in both groups
(Franke, Reimer, Philipp and Heemann 2003). In another European study, the
elimination of cyclosporine (CyA) from sirolimus, steroids and CyA combination
anti-rejection therapy resulted in improved QOL. QOL was measured using the
Kidney Transplant Questionnaire and the SF-36 at month three (time of
randomization) and months 12 and 24 after transplantation. Statistically significant
difference favoring sirolimus and steroid group were found on fatigue, vitality and
appearance scores. No treatment differences were observed in physical symptom,
uncertainty-fear, and emotion scores (Oberbauer et al. 2003). Siegal, Halbert and
McGuire (2002) examined the associations between the Life Satisfaction Index and
demographic factors, co-morbid condition; adverse effects of immunosuppressants,
and medication compliance in 3676 kidney transplant recipients in the USA. Mean
satisfaction scores were highest in persons who were older than 64 years, men, and
those who were married. Satisfaction scores were positively correlated with education
and income; scores was significantly lower among persons with medical co-
morbidities, persons who reported that adverse effects of medications were more
frequent, and persons who reported non-compliance with their medication regimen.
To date, much of the research that has set out to determine QOL before and after
renal transplant has focused upon the designated time point or static measurement of
QOL, defined in terms of vocational, medical status and classifiable psychiatric
disorders. However, little attention has been given to considering QOL as an
interactive entity in relationship to medical compliance with the transplant process
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and subsequent emotional well-being. Further, there has been very little attempt to
develop effective psychotherapeutic intervention as a means to address emotional,
medical compliance issues and subsequently improve QOL. This is particularly
worrying as dialysis patients diagnosed with of classifiable psychological disorders
and a history of non-compliance are often excluded or denied access to organ
transplant. Therefore, it was hypothesised that there is a direct relationship between
QOL, emotional states and compliance with the medical regime. Further, that the
determination of QOL before and after transplant is better utilised as an indication for
and as a means to determine, efficacy of psychotherapeutic intervention with a view
to improving emotional states and compliance behavior amongst renal patients. This
is in direct contrast to the tradition of using QOL as a psychosocial measurement tool
without any form of intervention. Such studies rely entirely upon the receipt of a
successful transplant, or not, as the case may be, to enhance QOL. Further, such
studies are not sensitive to the subtleties of emotional experiences that accompany the
increase or decrease in a patient's QOL.
The findings of the research abstracts presented in the thesis are threefold as
follows: firstly, that there is a relationship between QOL, emotional states and
compliance with medical treatment; secondly, that the emotional experiences of
transplant patients are much more complex than originally realized. Finally,
individual psychotherapy is an effective means of intervention amongst patients in
whom QOL is compromised by emotion issues. Therefore, QOL measurement should
be conducted as a progressive tool to understand and develop effective intervention,
as opposed to a static single measurement in time. This will improve patient
compliance with the post-transplant regime and subsequently lead to increased
longevity of the transplanted organ.
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The achievement of such an ambitious hypothesis has necessitated a multi-
disciplinary effort consisting of a transplant surgeon and psychotherapist. This
collaboration has facilitated an insight into the work of mental health professionals
along with the thought processes and clinical presentations of transplant patients.
However, the reader should not assume that attending to the emotional needs of the
patients is the sole prerogative of psychotherapists; any member ofthe transplant team
can find themselves face-to-face with a distraught or agitated patient. However, in
order to administer QOL assessments, detecting non-compliance or observing for
previously identified emotional themes amongst the patients participating in the
research presented, I underwent a three month period of in-house training by a
qualified medical sociologist and psychotherapist. During this time I learnt to monitor
the words spoken by the patients and the context in which they placed them. I also sat
in therapy sessions and evaluated the variety ofinstruments completed by the patient.
This was done with the permission of patients. This psycho-medical pairing has also
resulted in an appreciation of a pattern in which the emotional and compliance
behavior in patients tends to parallel the medical course of their illness. Dr L.S.
Baines, PhD, who is a qualified Psychotherapist, conducted the therapy sessions. The
Principal Investigator for all the projects described in thesis was Dr R.M. Jindal. The
hypothesis, design of the studies, analysis of results, follow-up and writing of the
manuscripts was done primarily by Dr R.M. Jindal with the assistance of Dr L.S.
Baines and Dr J.T. Joseph.
Much of the research presented in the abstracts has necessitated the utilisation of a
combined quantitative and qualitative methodology. From a quantitative perspective,
we have drawn from the traditions of medical and psychological sciences and utilised
the previously quantified SF-36, the LTMBS-scale and the BDI (Beck and Steer
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1987). We considered the suggestion that these measurements rely on patient self-
report and could be misleading. For example, the BDI looks from the outset as if it is
just assessing depression, and may lead the patient to distort the results of the tests.
However, the BDI does assess the potential for depressive symptoms across stable
versus unstable situational contexts, as does the LTMBS-scale in their respective
assessment areas. By virtue of their very nature of being self-report, they leave the
interpretation of the questions/statements to the patient. This risk is minimised by the
use of multiple-choice questions. While written input from the patient is kept to a
minimum as the questions statements only require either ticking or circling to indicate
the answer chosen, eliminating the opportunity for interviewer bias. Rather, patients
are able to evaluate themselves at their own (thought/reflection) pace, as opposed to
the pace dictated by the interviewer, far outweighs any potential problems.
In the studies presented here, we have combined quantitative with qualitative
analysis to understand, identify and intervene in emotional states amongst this patient
group. This has involved analysis of thematic, in-context, recurring states recalled by
patients during psychotherapy sessions and semi-structured interviews. By utilisation
of combined quantitative and qualitative methodology, we were able to understand the
subtle nuances of our patient's experience. Our study is limited to adult recipients of
kidney transplants as issues dealing with QOL in paediatric recipients of kidney
transplants involves numerous other variables such as growth, child development,
social and sexual issues.
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THEORETICAL FRAMEWORK:
PSYCHOTHERAPY
The concept of 'systematic' psychotherapy within the context of this thesis
SYSTEMIC INTEGRATIVE
refers to the manner in which patient's experiences infuse into different areas of their
lives. Further, it refers to the need for some semblance of order or understanding of
these issues if patients are to develop insight into their problems. The meaning of the
term 'integrative' in the context of psychotherapy has been defined in a two fold
manner by Erskine and Moursund (1988) working at the University of Illinois, USA,
as follows: Firstly, it refers to the process of integrating maladaptive personality traits
(e.g. defense mechanisms, ego structure, intra-psychic function) as a means to form a
more cohesive self. Secondly, it refers to the integration of a number of theories,
which in the context of the thesis are those of the psychodynamic, existential and
transpersonal. Therefore, it should be clear to the reader that the 'systematic' and
'integrative' components of the therapeutic intervention need to be compatible. In the
context of the work presented in the thesis, there is a common theme of 'heightened
sensitivity to time' that informs; guides and subsequently validates the therapeutic
process.
After the death of Freud in 1939, there was a broadening of the concept of
psychoanalysis away from viewing individuals as just biological beings, whose
personalities could be understood in terms of the psychosexual stages of development,
towards an approach that viewed individuals as social beings. The concept of social
beings incorporated the work of Kohut (1971, 1977), Mahler et al. (1975) and
Kemberg (1976, 1984) and their theories of 'self, generically known as the
psychodynamic approach. The psychodynamic approach views problems experienced
by patients in the present as having their origins in childhood experiences. Therefore,
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psychodynamic theorists believe that in adulthood, patients recreate adult
relationships that mimic the problematic ones of their childhoods. This phenomena is
termed 'projective identification' and is the pattern of interaction and behaviour that
therapist identify and use to disentangle troubled relationships of the past in
relationship to the present.
The Existential approach is based upon philosophers such as Heidegger
(1927), Sartre (1943), May (1950) and Laing (1960). The existential philosopher is
concerned to understand patient's problematic experiences of 'being in the world' in
the present in terms of their relationship with self, others and the physical world.
Existential therapists place ultimate responsibility for the creation and compilation of
above-mentioned aspects of experience upon the patient. In so doing, they draw upon
the self, within a broad context of individual-patient experience, such as decision-
making and choice, identity, isolation and interaction, love, time, death and freedom.
The Transpersonal approach perceives the psychotherapy process as an
opportunity to explore dimensions of all the above-mentioned experiences and
phenomena beyond the lived personal experience, a spiritual exploration. Sutich
(1986) described Transpersonal
Psychotherapy as being directed towards enabling the patient to achieve the
'realisation of an ultimate state' through a spiritual path. Transpersonal Psychotherapy
draws upon psycho-synthesis and the Jungian approach and ideas and techniques from
meditation, Chakras, dream-work, imagery, healing, Sufism, Buddhism and astrology.
The experience of ongoing chronic illness and major surgery causes these
patients to develop a heightened sensitivity to time in terms of time lost to chronic
illness, 'present time' focused upon survival and 'future time' remaining to them with
or without a transplant. Clarkson and Lapworth (1996) were the first to integrate
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psychodynamic, existential and transpersonal approaches, compiled to be sensitive to
'the evolution of time' and appears well suited to client groups suffering from chronic
illness. Further, it is capable of reaching across time, by virtue of its' integration of
existential (present), psychoanalytical (past) and transpersonal (future) perspectives,
essential to emotional stability and personal development after transplant. The ability
of this model to incorporate such an expanse oftime offers continuity throughout both
the psychotherapeutic and transplantation process, which are likely to run parallel to
each other. The emphasis is upon 'framework' as opposed to 'theory' or 'model', to
allow the therapist to accommodate patient needs. We have found that this form of
therapy best accommodates the needs of patients and reflects their heightened
sensitivity to time. Patients view their life through three time zones, namely the past
(time lost to chronic illness), present (based upon daily survival) and the future (time
remaining to them). During dialysis, the focus is very much on the present, which
manifests during therapy as doing what they need to do in order to survive, there is
little personal development during this time and they barely glance back (past) or
forward (future). After transplantation, patients are concerned about reconciling the
past lost to chronic illness. There is often much talk of 'getting back to normal' after
transplantation. However, 'normal' is defined in time past and is often not a realistic
baseline after transplantation, as time has moved on. Ordinarily, individuals develop,
or change over time (defined in terms of attitude, behaviour, values and perspective),
a phenomenon, which is often reflected in their interaction and the nature of their
relationships with others. However, for patients receiving dialysis, time and personal
development often stagnates, while family and friends continue to make progress in
their lives. Therefore, after transplantation, patients often find themselves in a sort of
'developmental limbo' in which they can flounder. Much of the therapist's work after
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transplantation involves helping the patient to redefine 'normality' based on their
present physical ability and emotional availability and gently contemplates the future.
Normality might be determined differently after transplantation but that does not
necessarily mean that it was inferior or any less worthy before. We often suggest to
patients that life might be different after transplantation, but not necessarily any less
meaningful than their pre-morbid life.
The theoretical integration or 'theory mushing' of different theoretical
orientations and techniques of psychotherapy came about in the hope that collectively
they would be more effective than the individual theories. Systemic Integrative
Psychotherapy integrates psychoanalysis (past), existential (present) and transpersonal
(future) theoretical models. In other words, it is based upon the need to consider needs
over a time span, which includes the past, the present and future perspectives. These
are recalled during therapy sessions and give continuity over the transplant process
over an uncertain period of time. This specific form of therapy places great emphasis
upon the concept of 'time'. More specifically, movement through time, a common
concern amongst kidney transplant patients. Time is described as spanning 'back'
(downwards) to the past, 'through' the present and 'upwards' to the future. Time
spent in therapy is considered to be a mere moment on the scale and the counselling
relationship relates to a point 'in time' of the patient's life. It has been suggested that
it exists existentially in the present as a working psychotherapeutic alliance in order to
accommodate current life experiences within the family, friendships and practicalities
which make up daily experiences which are often complicated by feelings of loss,
conflict and confusion. In tum, the relationship is likely to regress to the past as the
patient recalls early childhood and experiences of chronic illness which have led to
current feelings of conflict, confusion and loss. In considering the past, counselling
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relationship is subject to psychoanalytical concepts of transference and counter-
transference. As the past is left behind, it is thought that the future comes to be
contemplated as a more realistic option with emphasis upon the transpersonal. This is
largely uncharted territory for most patients, but amongst transplant patients, this
concept is particularly difficult to contemplate and is complicated by fear of rejection
of their organ. However, it is important that this aspect of uncertainty is overcome so
that the patient can begin to contemplate the future and the direction in which therapy
is heading.
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LITERATURE REVIEW
There are numerous studies examining QOL after kidney and pancreas
transplantation. We performed MEDLINE, the Cochrane Library, EMBASE, Cinahl,
PsycINFO, ASSIA, RCN journals, SERFILE 202 and World Information Nursing and
the World Wide Web for search using the terms 'Quality of life and kidney
transplants' and 'Quality of life and pancreas transplants'. Only articles in English
were included. Priority was given to articles that were prospective and randomised
and used controls and articles after 1995. We generally avoided case reports or
papers, which were in abstract form or were incomplete or duplicate publications. The
selected papers represent studies across the world.
Parameters used in these studies include physical and psychological well-
being and sexual function as well as the job satisfaction, income and social
functioning. One of the commonest questionnaire is the SF-36, which is a global QOL
instrument looking at eight scales- physical function, physical role, pain, perception of
general health, vitality, social function, emotional role and mental health. Other
instruments in use are the disease-specific QOL instrument such as the End Stage
Renal Disease Symptom Checklist, Kamofsky Index, Activities of Daily Living,
Nottingham Health Profile, BSI, SIP and Mini Mental State Examination.
Dew et al. (1997) reported in a meta-analysis of 14,750 patients that there was
clear evidence that QOL improved after transplantation, however, QOL of transplant
recipients did not generally improve to the level of matched healthy population. More
recently, it has been proposed that QOL questionnaires may be able to differentiate
between various immunosuppressive regimens. Shield, McGrath and Goss (1997)
evaluated QOL in recipients of kidney transplants who participated in the Phase III
trial of CyA versus tacrolimus. They recruited 303 patients and used a variety of
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instruments administered at week 6 and months 3, 6, and 12. They found that the
baseline scores were similar between the groups, the mean scores for patients with
rejection were lower versus patients not experiencing rejection; overall scores in the
two study arms were similar. Hilbrands, Hoitsma and Koene (1995) administered
QOL instruments to patients who were on standard immunosuppressive therapy (CyA
and prednisone) and then at three months allocated to either withdrawal of prednisone
or conversion of cyclosporine to azathioprine. They found that in both groups of
patients, scores improved progressively after transplantation reaching levels of
general population in Netherlands, acute or chronic rejection had a negative effect on
scores, while patients who were on CyA monotherapy had the best outcomes in terms
of psychosocial functioning. This positive effect was thought to be due to the
withdrawal of prednisone.
Most studies have found that the QOL improves after transplantation,
however, only few studies have undertaken the five-year surveys (Hilbrands,
Hoitsmma and Koene 1995; Dew et al. 1997; Pisani et al. 1997; Franke et al. 1999;
Gross et al. 2000; Fujisawa et al. 2000; Martin, Shireman, First and Whiting 2001;
Christensen, Raichle, Ehlers and Bertolatus 2002; Griva et al. 2002; Matas et al. 1998
and 2002a). Matas et al. (1996) looked at the employment patterns of 822 kidney
transplant recipients. They found that a significant proportion of patients who were
working or attending school before transplant continued to do so afterwards, while the
majority of those returning to work did so in the first year post-transplant. However,
with longer follow-up, more patients returned to work, major factor for dropping out
of full-time work was failure of the transplanted organ.
Unlike renal transplants, kidney-pancreas transplants carry significantly
higher morbidity. With experience, technical complications have diminished, but
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post-operative morbidity remains high. In a recent review, Sutherland et al. (2001)
have recommended early pancreas transplantation for labile diabetes. Even though the
transplant, as such contributes to morbidity and immunosuppressive medications
cause many side-effects, QOL, post-transplant, has been found to improve
significantly, especially in ameliorating the secondary complications of diabetes. The
major surgical complications of kidney transplants include graft thrombosis, renal
artery stenosis, wound infections, lymphoceles, side effects of anti-rejection therapy
such as hypertension, hyperlipidaemia, post-transplant diabetes and increased
susceptibility to infections and certain types of cancer. The overall incidence of
complications after kidney transplantation has decreased dramatically with improved
surgical techniques and patient-tailored anti-rejection therapy and prophylactic anti-
infection therapy (Jindal and Hariharan 1999; Hariharan et al. 2000; Bennet 2003). In
case of pancreas transplantation, there has also been dramatic improvement in both
short- and long-term survival, however, immediate complications continue to be a
major issue due to the very nature of the organ. In general, hospital stay and incidence
of complications after a pancreas transplant is 30% greater then after kidney
transplantation (Jindal, Revanur and Jardine 2002; Beneditti, SHeri, Gruessner and
Cicalese 2002).
Griva et al. (2002) compared HOOL in 76 living related and 271 cadaver
organ recipients, looking at the social, medical and psychological improvements after
transplants. They observed improved emotional well-being in all the patients.
However, living-related recipients expressed higher levels of feeling of guilt probably
because they continue to see the donors. In another such study from Japan, Isotani et
al. (2002) questioned 104 patients who underwent living donor nephrectomies, using
SF-36 survey and the questionnaire about donor satisfaction. They reported that QOL
21
of kidney donors was not affected by donor nephrectomy. Pace et al. (2002) compared
open versus laparoscopic donor nephrectomy and found that laparoscopic donor
nephrectomy gave a better QOL at marginally higher cost. It is clear that QOL in
recipients of live kidneys will be better than of those receiving cadaver kidneys as
these kidneys work straightaway and the long-term outcomes are better than cadaver
kidney transplants (Hariharan et al. 2000). There may also be decreased incidence of
acute rejection and therefore decreased burden of anti-rejection medications leading to
a reduction of side-effects (Jindal and Hariharan 1999). We will see an increase in
both live related and live unrelated transplants; however, we will have to be sensitive
to the emotional problems of both donors and recipients.
The demand for kidney transplants across the world far outweighs availability.
Advances in surgical techniques and in immunosuppressive therapy have made
kidney transplantation a routine procedure in most countries (Jindal and Hariharan
1999). Acute rejections, which generally occur in the first three months after
transplantation can be reversed in most cases, however, chronic rejection in the later
stages is still a major problem. The incidence of chronic rejection is approximately
15% per year. The magnitude of the problem is enormous, as five-year survival of
grafts is 31% for those with biopsy-proven chronic rejection versus 81% for those
without rejection. One year graft survival after cadaver transplant is now
approximately 88% (Jindal and Hariharan 1999); while the cumulative rate of graft
loss after the first year following transplantation is reported to be about 3% a year
(Jindal and Hariharan 1999). Therefore, there is ongoing demand for kidney
transplants.
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The situation in most Western countries suggests that the number of organ
donors has plateaued; according to the UNOS [United Network for Organ Sharing]
(the agency that regulates organ supply in the USA), there were 82,134 patients
waiting on the list for organs but only 8,324 patients received a kidney transplant this
year while there were 4,285 organ donors. Despite, extensive publicity and campaigns
to increase the number of cadaver organ donors, there has been very little impact. The
logical way to increase donor supply has been the increasing use of live donors for
kidneys and to a lesser extent for livers (Jindal and Hariharan 1999; Hariharan et al.
2000). Despite extensive public education, the number of deceased donors in the US
has essentially plateaued (3,714 in 2003, 6,183 in 2002, 6,082 in 2001 and 5,985 in
2000 according to UNOS statistics) while the number of live kidney transplants has
steadily increased (4,002 in 2003, 6,618 in 2002, 6,557 in 2001 and 5,867 in 2000
according to UNOS statistics). The overall mortality is 0.03%, which is the same as
getting killed in a random car accident on the highway. The donor of a kidney
transplant is not denied life insurance and the incidence of renal failure, diabetes,
hypertension of other medical issues are not increased as comprehensively shown by a
landmark study by Najarian et al. (1992). Investigators at the University of Minnesota
studied kidney donors and their siblings 20 years after donation by comparing renal
function, blood pressure, and proteinuria. In 57 donors, mean serum creatinine, blood
urea nitrogen, creatinine clearance, and blood pressure did not differ from siblings.
They also surveyed all North American transplant centres and found that there were
17 peri-operative deaths after living donation, an estimate mortality to be 0.03%.
Despite these reassuring statistics, donors should be warned of the risks associated
with surgery and should be seen by a physician and mental health professional who is
independent of the transplant team performing the surgery. Donors usually also
23
undergo a detailed physical examination and comprehensive battery of investigations
to rule out any medical or psychological contraindication to surgery. Studies from
both the US and UK have confirmed that altruism and a sense of moral obligation
were the prime motivational influences with the spontaneity of decision-making,
however all appropriate precautions should be taken to prevent commercialisation of
organs and protect the interests of the donor (McMaster and Mirza 1995; Eggeling
1999; Adams et al. 2002).
It has also been shown that recipients of unrelated kidney transplants even
without good tissue match do as well as fully matched cadaver organs (Hariharan et
aI.2000). Added to this is the fact that surgery, anaesthesia and postoperative care of
live organ donors has improved dramatically, making this procedure fairly
straightforward. There is also the introduction of laparoscopic technique for removing
kidneys from live donors, the hospital stay is shortened as much as by 50% (average
hospital stay three days versus 6 - 7 days for the open procedure) and patients require
less analgesia and return to work sooner (pace et al. 2002). Therefore, live kidney
donation, both from related and unrelated has appeared as a major advance in kidney
transplantation. Living donation eliminates the recipient's need for placement on the
national waiting list. Transplant surgery can be scheduled at a mutually agreed upon
time rather than performed as an emergency operation. Because the operation can be
scheduled in advance, the recipient may begin taking anti-rejection medications two
days before the operation. This decreases the risk of organ rejection. Transplants from
living donors are more successful, because there is a better tissue match between the
living donor and the recipient and the cold storage time is minimal (Jindal and
Hariharan 1999; Hariharan et al. 2000). This higher rate of compatibility also
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decreases the risk of organ rejection. Perhaps the most important aspect of living
donation to the donor is the psychological benefit. The recipient can experience
positive feelings knowing that the gift came from a loved one or a caring stranger,
while the donor experiences the satisfaction of knowing that he or she has contributed
to the improved health of the recipient.
In the United States, UNOS maintains the national list of patients waiting for
deceased organ donor transplants. UNOS' computer matches patients to donor organs
according to objective criteria such as blood and tissue type, immune status, medical
urgency and time spent on the waiting list. The ranking system determines which
patient is offered the available organ. In addition to deceased (person declared brain
dead) donor transplants, patients may also receive organs from living donors. In 2001,
there were 24,101 organ transplants performed in the United States. Of these 6,082
were living donor transplants. Living donation offers an alternative for individuals
awaiting transplantation and increases the existing organ supply (www.unos.org).
Other countries have organizations similar to UNOS to regulate the supply of organs;
'UK Transplant' is an example in the UK and 'Euro-Transplant' in some European
countries.
In general, live kidneys work straight away and there is not need for dialysis
after surgery (Joseph and Jindal 2002). In our own study, we had a 50% incidence of
delayed graft function; these patients required dialysis and increased hospital stay
(Joseph and JindaI2002). But more important is the fact that live kidneys have a clear
long-term advantage. Hariharan et al. (2000) analysed the influence of demographic
characteristics (age, sex, and race). transplant-related variables (living or cadaver
donor. panel-reactive antibody titer. extent of HLA matching, and cold-ischaemia
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time), and post-transplantation variables (presence or absence of acute rejection,
delayed graft function, and therapy with mycophenolate mofetil and tacrolimus) on
graft survival for all 93,934 renal transplantations performed in the United States
between 1988 and 1996. A regression analysis adjusted for these variables was used
to estimate the risk of graft failure within the first year and more than one year after
transplantation. From 1988 to 1996, the one-year survival rate for grafts from living
donors increased from 88.8 to 93.9 percent, and the rate for cadaver grafts increased
from 75.7 to 87.7 percent. But more dramatically, the half-life for grafts from living
donors increased steadily from 12.7 to 21.6 years, and that for cadaver grafts
increased from 7.9 to 13.8 years. After censoring of data for patients who died with
functioning grafts, the half-life for grafts from living donors increased from 16.9 years
to 35.9 years, and that for cadaver grafts increased from 11.0 years to 19.5 years.
Kahan (2000) recently summarised the selection criteria for transplantation as
follows: 'accepted notion of benefit' (medical need, life remaining and post-transplant
quality of life); 'patient's rights' (based upon the right of every patient to
transplantation if they so wish); 'cost effectiveness' (on the basis of best economic
outcome); and 'scientific progress' (whether the patient's treatment will advance the
medical science). These concepts are designed to assist the physician in allocating
scarce resource of organs amongst an increasing number of patients. In general,
psychosocial assessments have centred upon compliance, family support and the
existence of any psychiatric disorders. Primary psychiatric contraindications generally
include history of substance abuse, psychosis, suicide attempts, and dementia and
borderline personality.
The principal assessment tools include the Psychosocial Assessment of
Candidates for Transplantation (PACT), the Psychosocial Levels System (PLS), and
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the Transplant Evaluating Rating Scale (TERS). The BDI (Beck and Steer 1987), the
SCL-90-L (Derogatis 1992) and the shorter version BSI (Derogatis 1993) and
Minnesota Multiphase Personality Inventory (MMPI) have also featured in a number
of psychosocial studies amongst renal patients. PACT focuses upon psychological
variables such as substance abuse, compliance, social support, psychopathology,
lifestyle and knowledge of the transplant process. However, PACT does not predict
transplant outcomes as such, rather it highlights the correlation between decisions to
accept or exclude the view of different assessors between recipients.
The PLS evaluates the correlation of decisions to include or exclude patients,
based upon past coping skills, psychiatric history, affect, mental health status, support
and susceptibility to anxiety. Patients are subsequently classified into three levels of
suitability for transplantation. Level One patient is characterised by not having any
psychiatric history, appropriate social responses and good social support. Level Two
patients are likely to have a history of depression, agitation or dysphoria and only
satisfactory levels of social support at diagnosis. While those patients classified at
Level three are liable to have a significant psychiatric history of substance abuse or
major depression and/or suicidal ideation.
The TERS evaluates ten psychosocial aspects of a patients functioning and is
an expansion of the PLS. In addition to the above-mentioned TERS, PLS level-I
candidates may display cluster C traits (avoidant, dependent or obsessive-compulsive
personality disorders). Level-2 patients may have cluster C traits or a combination of
symptoms from clusters a (paranoid, schizoid, schizotypical personality disorders)
and clusters B (anti-social, borderline, histrionic, narcissistic personality disorder).
Level-S candidates have cluster A and B diagnosis. The use of these have been aimed
at the development a single or multiple measure of psychosocial suitability for
27
transplantation, the underlining criteria being whether or not the patient would be
likely or capable of complying with the medical regime. However, despite the use of
rating tools, there is little consensus about the most effective method of predicting
outcome.
To measure QOL, the most widely used generic questionnaires are the SIP
(Bergner, Bobbit, Carter and Gilson 1981), Nottingham Health Profile (Hunt,
McKenna, McEwen and Papp 1981) and the SF-36, the latter instrument has been
condensed to SF-12, a measure validated in numerous disease states and in many
countries (Ware Jr and Sherborne 1992). The disease-specific questionnaires in
transplantation, which have been validated, are the Kidney Transplant Questionnaire
(Laupacis et al. 1996) and the ESRD-SC (Franke et al. 1999). We have suggested that
in addition to QOL, we should also measure compliance with medications and
emotional well-being by LTMBS-scale (de Geest et al. 1995, Baines, Joseph and
Jindal 2002a) and BDI respectively. Although other instruments may be used for this
purpose, there are as yet no clear guidelines in this regard.
However, the validity (what the patient thinks in the here and now or
concurrent validity) reliability (predictive validity, or whether the patient will do what
they say they will) of the QOL tools utilised in the research abstracts themselves is
likely to be high as they are composed of factual as opposed to non-factual questions.
The questions also tend to flow in sets, or logical sequence, thereby reinforcing and
re-testing for incongruence in or between themes being measured. The studies we
have reviewed use a variety of questionnaires; the selection of QOL instrument was
dependent on the bias of the investigators making it difficult to compare studies
across centres. The majority of studies are retrospective and there is wide difference
in the cultural patterns, sample size and duration of follow-up. Another problem with
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the self-reported studies is the poor response from patients. None of the studies
reported on the effect of self-reported questionnaires on the patient's ability to
influence their physicians or indeed the physician's ability to better understand
concerns of their patients. Transplant physicians and psychologists working in teams
rather than in isolation may remedy the situation. There was also no information on
the additional resources required to conduct these studies; and while these studies
were found to be useful in clinical trials, there are no data on their usefulness in actual
practice. Clearly, provision must be made for additional resources for the
administration of instruments and appropriate psychological intervention. We are
encouraged by the recent guidelines by the American Society of Transplantation
(Kasiske et al. 2002) that psychosocial evaluation of transplant candidates should be
done by a professional who understands that bias may be a factor in patients denied a
chance to go on the waiting list. To avoid bias, the potential recipient should have
adequate cognitive ability to understand the risklbenefit of transplantation, manage
long-term anti-rejection therapy and the importance for life-long compliance. A
Psychologist generally administers the questionnaires described above; however, in
some centres, a qualified Social Worker with training in psychological methodologies
can also do this work.
The studies we have reviewed are generally of small size with short-term
follow-up and there is no consistency of the instrument used to evaluate QOL. There
has been an exponential increase in the number of publications on QOL after solid
organ transplants from zero in 1970 to 120 in 1992 (Joralemon and Fujinaga 1996),
however, studies still do not include baseline assessment. Investigators used 159
different QOL instruments in 75 publications (Joralemon and Fujinaga 1996), while
some investigators used multiple QOL instruments on the same group of patients,
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making it impossible to find commonalities for inter-centre comparison. It is also
hypothesized that negative results are omitted or explained away while the transplant
patient's sense of indebtedness to the transplant surgeon and the collective experience
of loyalty to the transplantation community is not taken into account as positive biases
for QOL research (Joralemon and Fujinaga 1996).
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CONTRIBUTION TO mE KNOWLEDGE BASE
I have co-authored a book and carried out original clinical studies in this field. I
summarise these in the following pages:
Book author:
The struggle for life: A psychological perspective of kidney disease and
transplantation, by Lyndsay S. Baines and Rahul M. Jindal. Publisher: Greenwood
Publishing Group, Westport, CT, USA. Date for release: December 2003. ISBN: 0-
86569-323-4 (www.greenwood.com)
Manuscripts discussed in this thesis:
Joseph JT, Baines, LS, Morris MC, Jindal RM. Quality of life after kidney and
pancreas transplantation. American Journal of Kidney Diseases 2003; 42:431-445.
Baines LS, Jindal RM. Non-compliance in patients receiving haemodialysis: An in-
dept review. Nephron 2000; 85:1-7.
Baines LS, Joseph IT, Jindal RM. Compliance and late acute rejection after kidney
transplantation: A psycho-medical perspective. Clinical Transplantation 2002; 16:69-
73.
Baines, LS, Joseph IT, Jindal RM. Emotional issues after kidney transplantation: A
prospective psychotherapeutic study. Clinical Transplantation 2002; 16:455.
Baines LS, Jindal RM. Loss of the imagined past: an obstacle to emotional recovery
to medical compliance. Progress in Transplantation 2002; 12:305-308.
Jindal RM, Joseph JT, Morris MC, Santella RN, Baines LS. Non-compliance after
kidney transplantation: A systematic review. In Press: Clinical Transplantation
Proceedings.
Baines LS, Joseph JT, Morris MC, Jindal RM. Group versus individual
psychotherapy: Addressing emotional problems in recipients of kidney transplants. In
Press: Kidney International.
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My contribution to the state of knowledge:
The four unique contributions to the field detailed in this thesis are as follows:
0) Patient empowerment: To determine the emotional impact of patient empowerment
on compliance with medications in patients who had experienced late acute rejection,
we requested that they complete a modified version of the LTMBS-scale, a self-report
questionnaire; a 27-item instrument depicting a variety of social situations in which
the patient might be required to take their medications. We identified 24 patients over
a six-year period that suffered late acute rejection. It was seen that patients were only
reasonably confident (mean score 2.17) in taking their medications. All patients
demonstrated significantly lower self-efficacy in relationship to items relating to
physical and psychological symptoms and psychological symptoms that affected their
well-being.
cm Effect of psychotherapeutic program on emotional states after kidney
transplantation: We designed a prospective study utilising the recurring emotional
states as recalled by patients during psychotherapy sessions to understand and
intervene in emotional issues in adult recipients of first cadaver kidney transplants.
Forty-nine recipients of first cadaver kidney transplants were subjected to 12 sessions
(at weekly intervals) of psychotherapy within three months of receiving their
transplant. The BOI was utilised as a measure of change in emotional state, pre-
therapy, at 3, 6, 9 and 12 months. A higher score on BDI was suggestive of
psychological dysfunction. In the first instance, data was analysed within a
quantitative framework, by virtue of the BOL In the second instance, data was
considered in terms of recurring themes described by patients during psychotherapy
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and was analyzed qualitatively. In the third instance, both qualitative and qualitative
data was considered in terms of individual patient's ability to achieve some feeling of
having implemented some social, relational and vocational equilibrium into their
everyday life. Recipients of live kidneys, pediatric transplants and patients who
received more than one transplant were excluded, as emotional issues are different in
this cohort of patients. All patients have completed one year of follow up. None ofthe
patients were on antidepressant medication before or after therapy. The results
reported in this paper form the 49 patients in the individual arm of the study. All the
patients in our study happened to be Caucasians. There was significant improvement
in the BDI scores following therapy. The mean score was 26.3 ± 7.9 before and 20.5 ±
8.8 after therapy (p=O.OOI); the lowering of the scores remained sustained at 12
months. Multivariate analysis of age, gender, employment status, duration of dialysis
(if in dialysis for more than three years) and psychotherapy given before
transplantation did not affect the results of our study. For the qualitative aspect of the
study, we grouped the emotional problems as expressed by the patients into three
recurring themes, (I) fear of rejection, (H) feelings of paradoxical loss after a
successful transplant despite having received a successful transplant (iii) the
psychological integration of the newly acquired kidney. We found that
psychotherapeutic intervention was an effective means of addressing emotional
problems in recipients of kidney transplants. The recurring themes as identified above
provided a baseline for psychotherapeutic exploration and resolution of these issues.
Successful resolution of these issues was associated with lower BDI scores and the re-
definition of normality in daily living.
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(iii) Randomised controlled study to determine the efficacy of individual or group
psychotherapy amongst kidney transplant patients: Recipients of kidney transplant
have been shown to develop emotional problems. The research was founded upon the
premise that by its' very nature group therapy might be more cost effective than
individual therapy, as up to ten patients could be treated during one hour session,
whereas it would take ten hours to treat ten patients in individual psychotherapy.
While the small number of studies that have been carried out to determine the
effectiveness of group psychotherapy amongst dialysis and transplant patients have
suggested that group therapy is effective in alleviating emotional states and
facilitating adjustment post-transplant (Freedman, 1983; Abbey et al. 1990), its'
therapeutic effectiveness has not been compared to individual psychotherapy. We
have compared the efficacy of two modalities of therapy in recipients of kidney
transplants versus control patients who did not receive therapy. Recipients of first
cadaver kidney transplants were randomised into two groups, to receive a 12-week
course of group or individual psychotherapy. Control arm of the study comprised of
37 consecutive patients who had received a first cadaver kidney. Recipients of live
kidney transplants and patients who received more than one kidney transplant were
excluded as these patients have different emotional issues. We recruited 89 recipients
of first cadaver kidney transplants into the study. They were randomly allocated in to
the two study groups, 49 for individual therapy and 40 for group therapy. Of these, 82
patients completed 12weeks of therapy (45 patients from the individual treatment arm
and 37 from the group therapy arm). Fifty-five patients completed one-year follow-up
(33 in individual therapy and 32 in the group therapy). Patients were required to
complete the BDI before starting therapy and at 3, 6, 9, 12 months follow-up, The
BDI is a questionnaire that can be completed by the patients. It presents patients with
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a series of emotional scenarios that they have to rate according to their perceived
severity. It is also quite quick to complete and therefore could be administered in
outpatient clinics. The mean score was 26.3 ± 7.9 before and 20.5 ± 8.8 after therapy
in the individual treatment group (p=O.OOI).This was in comparison with a mean
score of 29.8 ± 3.9 before and 27.1 ± 3.9 after therapy for the group therapy arm (p=
0.01). Improvement appeared to be more significant in the individual therapy
compared to group therapy (p= 0.01). Lowering of scores was progressive and
sustained (p=O.Ol). In the control arm, mean score was 9.4 ± 5.4 before and 20.5 ± 5.5
at the end of the first year (p=0.005) suggesting a significant worsening of BD!
scores. The control group's lower starting BDI scores were attributed to them not
thinking about their psychological status too deeply as they were not expecting to
receive therapy. This is contemplated in the corresponding abstract below in more
depth and termed the 'barrier of gratefulness'. Another reason could be "paradoxical"
effect seen in certain groups of people such as those living in social isolation;
unemployment, poverty or adverse living conditions may still report a positive life
satisfaction. This probably reflects their accommodation to adverse conditions and
does not imply that they would not wish to improve their life circumstances should
the opportunity arise in the form of better medications, rehabilitation of job
opportunities. They have probably made peace with themselves and the world.
Occasionally some patients when exposed to a positive intervention may give
decreased QOL from the baseline. This simply means that the patients are now more
aware of the opportunities and are eager to improve their lives even more (Lehman,
Postrado and Rachuba 1993).
Multivariate analysis of age, gender, employment status, duration of dialysis and
psychotherapy received at any time before transplantation did not affect results. We
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concluded that both individual and group psychotherapy were beneficial to our
patients, however, individual therapy was found to result in lower BDI scores versus
group therapy at the end of treatment period.
(iv) Coming to terms with the 'imagined past': Our research has suggested that even
after a successful kidney transplant, patients may present with feelings of
bereavement, grief or low mood that might appear paradoxical to both patient and
staff, given that they have just received a much desired kidney transplant. We propose
that this sense of bereavement should be considered in terms of an imagined past
which may help to understand the patient's current mood changes and medical non-
compliance. We have used the concept of Systemic Integrative Psychotherapy in a
case report to analyse change in a patient's life. Based on our research, we suggest
that feelings of bereavement and grief are generated as patients come to terms with
their past which has been irretrievably lost to chronic illness and contemplate their
future. Feelings of grief and bereavement in the post-transplant period may be due to
the loss of an imagined past, and must be differentiated from the bereavement the
patient feels for the donor and the donor family. If these feeling of loss are not
resolved it can lead to social isolation and medical non-compliance.
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ANALYSIS AND CRITIQUE
These are divided into the following sections:
(i) Quality of life in relationship to medical compliance:
Psychosocial issues and compliance are increasingly discussed in relationship
to QOL. Compliance is generally considered in terms of the physician's ability to
influence the patient and the patient's willingness to respond. Compliance amongst
patients undergoing dialysis and after transplantation has become an important issue
as non-compliance with the primary treatment regime leads to complications and even
death. The problem of non-compliance is thought to be particularly acute amongst the
lower socio-economic groups (Leggat et at. 1998), in patients between 20-30 years of
age, females (Alexander and Sehgal 1998) and in patients of minority race such as
African-Americans in the USA (Alexander and Sehgal 1998; Baines and Jindal 2000;
Baines, Hamilton and Jindal 200 I). Furthermore, patients who do not adequately
comply with dialysis are less likely to be placed on the waiting list for kidney
transplants. This is particularly true in women from black or from lower socio-
economic groups who are more likely not to complete the transplant selection process,
and therefore, have higher rates of morbidity than those patients who do comply and
receive a kidney transplant (Alexander and Sehgal 1998; Baines and Jindal 2000). It
has also been shown that non-compliance continues to be a major factor resulting in
graft loss in the 1990s (Matas et al. 2002).
Patients who do not comply with the medical regimen and lose their grafts
may be denied a second transplant, an area of considerable controversy and debate.
Furthermore, health care financing is assuming a central role in our society. Patients
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who lose their transplants due to non-compliance will result in significant drain on
finances as these patients are placed back on dialysis; a modality of treatment more
expensive than a functioning transplant. It is estimated that over 25% of patients who
enter into clinical trials of anti-rejection drugs may be non-compliant and hence
influence the results of these trials (Leggat et al. 1998).
A variety of validated instruments have been described to assess and in some
cases predict non-compliance after a kidney transplant. These methods include pill
counts, clinic attendance, drug levels and self-administered questionnaires. Each of
these methods has pitfalls and may not be equally applicable to all patients.
We have applied meta-analytic techniques to the literature on medical non-
compliance after kidney transplantation to enable a consensus to be reached in this
important area. The aim of this study was to identify patients at risk for non-
compliance after kidney transplant. Further work is required to identify the best
instrument to identify patients at risk of medical non-compliance after a kidney
transplant. Our study is limited to patients receiving kidney transplants as this group
form the largest cohort of patients receiving a solid organ transplant.
Two authors searched independently using the Medline followed by hand
searching. The most recent search was done in June of2001. The search included the
terms: compliance, non-compliance, medical compliance and kidney transplants,
transplantation, organ transplantation and medical compliance/non-compliance.
Additional reports were identified from the reference lists of key manuscripts and
review articles. For the analysis of data, only peer-reviewed articles in English
language journals were considered. Only manuscripts in the CyA era and involving
adult recipients of kidney transplants were included. Data was extracted by two
authors and checked for accuracy by a third author. Tables of the collected data were
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prepared for analysis. None of the papers reported a randomised trial; the majority of
the studies were of a descriptive nature. The selected papers were prospective in
which questionnaires were given to recipients who already had functioning kidney
transplants.
Frazier, Davis-Ali and Dahl (1994) sent detailed questionnaires to 500
recipients of renal transplants at the University of Minnesota of which 49% were
returned. They used a variety of standardised instruments such as the BDI, BSI,
Inventory of Social Supportive Behaviours (ISSB) and Multidimensional Health
Locus of Control (MHLC). They analysed their data using multiple regressions.
Siegal and Greenstein (1999) prospectively sent questionnaires to 2500 patients in US
transplant centres of which 1402 returned, of which 22.4% reported some level of
non-compliance with their medications after renal transplant. These patients were
over 18 years of age and were on CyA therapy and had a functioning transplant. In
their study, non-compliance was scaled from 1 (never forgot) to 8 (forget every day).
For each variable, they calculated the frequency, means, percentages and standard
deviations and then logistic regression analyses were used to identify predictors of
non-compliance. Cluster analysis was used to identify groups of noncompliant
patients based on similarities with respect to variables identified by logistic
regression.
Raiz, Kilty, Henry and Ferguson (1999) conducted a postal survey of 712
patients from the Ohio State University Medical Centre Who were 18 years old and
had a primary renal transplant for at least 12 months. They used the Dillman's method
for mailed surveys with analysis by multiple regressions. Usable data was obtained
from 50% of the patients. Didlake, Greyfus, Kerman, Van Buren and Kahan (1988)
from the University of Texas Medical School at Houston, USA, performed a mail
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survey of 295 patients who had received a kidney transplant between 1980 and 1986
and were compared with 70 patients who had a functioning transplant for at least 18
months. They defined non-compliance when the patients presented with rejection
episodes and were interviewed by two members of the transplant team and the blood
levels of CyA were sub-therapeutic. They analysed the mean values of population
parameters using t-tests.
Schweizer et al. (1990) performed a combination of retrospective and
prospective analysis of patients receiving kidney, liver and heart transplants at the
Hartford Transplant Centre, Hartford, CT, USA. Their study was divided into
retrospective chart review of 260 patients between 1971 and 1984 and a prospective
study of 196 patients between 1984 and 1987. They excluded patients who lost their
transplants in the first three months. The results were analysed descriptively. de Geest
et al. (1995) performed a descriptive cross-sectional study from the Catholic
University of Leuven, Belgium, on 150 recipients of kidney transplants who were at
least 18 years old and one year after transplant. All but two patients were recruited
and they were SUbjectedto interviews and psychometric tests. These authors used a
variety of statistical analyses, which included Wilcoxon rank sum test and Student's t
test for independent variables. Logistic regression analysis was applied to determine
which variables or combinations of variables best predicted whether a patient
belonged to the compliant or non-compliant group.
The major difficulty faced in reviewing the selected papers was that no two
papers presented data or analyses on the same outcomes in exactly the same manner.
This made impossible the conduct of a formal meta-analysis. In its' place we have
selected, as noted above, a list of potential correlates with non-compliance and have
tabulated for each paper whether or not each potential variate was statistically
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significantly related to non-compliance. Unfortunately some papers reported only
univariate associations, some only multivariate associations and some both. The
nature of these associations is indicated in the tabulations.
We identified 26 papers, which report on medical non-compliance after kidney
transplantation. To analyse the different factors affecting medical non-compliance
after kidney transplantation, we selected the manuscript by Frazier, Davis-Ali and
Dahl (1994) as a template against which other studies were analysed. We selected this
manuscript empirically as these authors analysed the majority of factors implicated in
non-compliance. These factors were age, race, gender, martial status, and income, and
employment, number of transplants, emotional and mental issues (anxiety, hostility,
depression, distress, stress, chance, pain and coping). Other variables analysed were
infection, type of transplant (cadaver or living), time since transplant, US born,
education, diabetes, number of rejection episodes, dose of prednisone, tremor, clinic
attendance, distance, dialysis compliance and treated rejection episodes. We also took
into account the self-care agency score, self-efficacy score and situational operational
knowledge.
Patients who were older, married, and male and had a higher income were
significantly more compliant with medications in paper by Frazier et al. (1994). The
numbers were too small for analysis in paper by Kiley, Lam and Pollak (1993), while
in paper by Siegal and Greenstein (1999); younger patients and white-collar
employment status were significant factors leading to non-compliance. Didlake et al.
(1988) found that Caucasians and older age were associated with greater compliance.
In paper by Schweizer et al. (1990), blacks and younger recipients of kidney
transplants were more non-compliant, while De Geest et al. (1995) found that single
or divorced patients were significantly more non-compliant versus the married.
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In manuscript by Frazier et al. (1994), recipients with a history of previous
transplant were less compliant and those who had been transplanted a longer time ago
were less compliant with follow regimen than were recipients who were more recently
transplanted. In manuscript by Siegal and Greenstein (1999), recipients who received
a living transplant, had received a transplant long time ago, had no history of diabetes
and had a history of infection and were born outside the US were more non-
compliant. In manuscript by Raiz et al. (1999), transplant type and other transplant-
related characteristics were not important. In manuscripts by Schweizer et al. (1990)
and by De Geest et al. (1995), transplant characteristics were also not important. In
manuscript by Didlake et al. (1988), no difference was seen in the type of transplant,
duration of pre-transplant dialysis, primary or re-transplant but the important
differences in the non-compliant group were greater then one rejection episode,
prednisone dose, presence of tremor, greater distance from the clinic, dialysis
compliance and greater rejection episodes.
Non-compliant patients were associated with greater emotional distress, higher
transplant-related stress and the belief that health outcomes were due to chance and
the use of avoidant coping strategies. In manuscript by Raiz et al. (1999), non-
compliant patients had greater anxiety. In manuscript by De Geest et al. (1995),
compliant patients had a higher level of self-care agency, perceived self-efficacy of
long-term medication and higher situational-operational knowledge.
The half-life of transplants has increased steadily, cadaver kidney transplants
to 9-11 years and 15-17 years for living transplants. This has meant that each centre is
following larger numbers of transplants; current restrictions of health care financing
do not allow each patient to be seen by a qualified therapist to address psychosocial
concerns. Some of these unresolved concerns may lead to non-compliance with
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medications. It is estimated that 25% of this cohort of patients may be non-compliant
with medications; one-to-one therapy with a qualified therapist would be prohibitively
expensive. In this scenario, we suggest that specific groups of patients be given
special attention to increase the level of compliance such as younger, female, and
unmarried and non-Caucasians. Other specific patients groups who may require
special attention are recipients of living transplants and were transplanted longer time
ago with a history of previous transplant. In addition, patients displaying emotional
problems such as anxiety, hostility, depression, distress, lack of coping and avoidant
behaviours may be targeted for special attention by qualified therapists to increase
medical compliance.
Another issue that needs to be considered is if addressing emotional problems
leads to an increased compliance with medications. Although we have shown that
there is an improvement in BDI scores after systematic integrative psychotherapy
therapy, it is not known if this will lead to improved compliance with medications.
The lack of a standardised instrument for predicting or measuring non-compliance
will make it difficult to prove or disprove the latter point. A variety of self-assessment
questionnaires have been devised to investigate patient compliance with medications,
however, these are useful only after the patient has lost the transplant. In addition to
group therapy, we plan to assess the questionnaire devised by de Geest et al. (1995) to
profile patient concerns regarding the side effects of medications.
From our study, we concluded that patients who are at a higher risk of non-
compliance after kidney transplants were younger, female, unmarried and non-
Caucasians. Patients who were recipients of living transplants and were transplanted
longer time ago with a history of previous transplant were also at risk of non-
compliance. In general, all patients displaying emotional problems such as anxiety,
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hostility, depression, distress, lack of coping and avoidant behaviours were also at risk
of non-compliance after kidney transplantation.
(ii) Quality of life in relationship to psychosocial well being in recipients of kidney
transplants:
Skotzko, Stove, Wright, Kendall and Dew (2001) carried out a survey to
determine the views of the transplant community on psychosocial issues. They found
that there was overwhelming support for providing psychosocial support both before
and after transplant to increase rehabilitation of patients. There was also a broad
support for substance abuse treatment programs for recipients of organ transplants;
most respondents also acknowledged the impact of psychosocial factors on
compliance, QOL and survival. Respondents to this survey also pointed to the need
for formal studies of psychosocial intervention on cost and resource utilisation, which
will convince health service planners to adequately fund such programs.
Research into psychosocial issues amongst this group of patients has tended to
reflect the quantitative tradition of medicine (Baines and Jindal 2000). However, the
subtleties of psychosocial intervention and subsequent change in behaviour and
emotional states are more difficult to measure. This leaves the transplant team unable
to translate medical or psychosocial research findings into practice, or to determine
what might be the best intervention for an emotionally distressed patient at a
particular point in time. There has also been a concerted effort to utilise these findings
in the construction of 'scales' and 'assessments' to identify emotional distress, or
predict post-transplant compliance and subsequently exclude such patients from the
transplant process. However, such seales and assessments typify patients emotionally
at the point of implementation and do not allow for the process of individual change
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and intervention. Also, often they do not accommodate the unpredictable manner in
which ongoing chronic illness compromises patients socially, politically and
economically. Despite these shortcomings, there is a clear need to devise an
instrument to capture psychological issues at a particular time point and to identify
groups of patients who need early intervention. There are specific instruments, which
can be used to identify groups of patients who need early intervention such as the
BDI, the SCL-90-R or the BSI.
(iii) Strategies to enhance OOL after kidney transplantation:
(al Patient empowerment: There is an increasing trend to involve patients directly in
treatment planning which in tum may lead to increased compliance. However, there
has been little legislative support for this position. Empowerment does not come
about by some miraculous process of osmosis, hut through the acquisition of
communicative and behavioural competence on the part of both the staff and the
patient. Skills, which may well, be lacking amongst patients from lower socio-
economic groups who might be easily overwhelmed by the professional classes and/or
whose confidence and self-esteem have been eroded by chronic illness. These patients
will need to be presented with empowerment as a multi-component educational
package that may utilise modelling, coaching, feedback and homework assignments,
all conducted within a supportive and developmental framework. Patient
empowerment is an approach to health care that advocates for the active involvement
of patients in their treatment. This involves educating patients about their care
options, the decision making process, treatment goals, and administering and
controlling care input, with the aim of achieving optimal outcomes in terms of
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treatment and patient satisfaction (Brennan and Saffran, 2003). Research conducted
by Roberts (1998) at North-Eastern University, Boston, studied the active promotion
of patient empowerment through 'liberating education' and referred to patients as
being 'oppressed' as a result of 'medical domination'. Recognition of these issues is
all very helpful but it is difficult to put into practice. To date the implementation of
patient empowerment has taken a number of formats. These may be combining
treatment goals with treatment options (McHale and Seidman 2002), patients
participating in their own assessment (Mitcheson and Cowley 2003), giving patients
an active role in the treatment (Salmon and Hall 2003), educational programmes
(Roberts 1998) and through the empowerment of nursing staff (Kuokkanen and
Katajisto 2003).
McHale and Seidman (2002) combined treatment goals with treatment options
in metastatic breast cancer. They found that through acknowledging and incorporating
patient-led treatment goals into their therapeutic program, patients were more likely to
comply with treatment. Mitcheson and Cowley (2003) in their study of the
relationship between health visitors and their patients developed this concept a stage
further by involving patients in the assessment stage of their health needs and
subsequent health visitor intervention. However, their findings suggested that while
health visitors were well motivated towards patient empowerment, they were
hampered by the nature of the assessment tool that assumed that a families health
needs could be predicted in advance as opposed to being responsive to patient's
changing needs.
Empowerment has also become an issue amongst the nursing profession and
linked to job satisfaction, further training and commitment. In particular,
empowerment has been seen as an essential pre-requisite for leadership and the
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profession of collegial support (Kuokkanen and Katajisto 2003). Patient
empowerment has developed alongside medical accountability in the form of
'informed consent', or the need for doctors to obtain patient's consent before medical
procedures and to inform patients of any risks. This has developed partly as a
response to judicial edits and partly as a result of the recognition of the need to be
pro-active in obtaining consent and informing patients of the treatment process.
Luderitz and Wolpert (2003) developed informed consent guidelines for patients
undergoing implantation of pacemakers. They pointed to the need for
comprehensiveness in terms how consent is delivered, in simple easily understood
language, the form of delivery, written as opposed to verbal, and detail of
complication rates and post-treatment QOL. In a study amongst dermatology patients
who were exposed to informed consent procedures, Fleischman and Garcia (2003)
found that less than a mere 26.5% of patients recalled being informed of ten possible
complications twenty minutes after being informed. Therefore, patient empowerment
has to be incorporated as part of the philosophy of an entire hospital as well as
individual services within the hospital.
Baines, Joseph and Jindal (2002a) retrospectively analysed the case records of
patients who had their first cadaver renal transplantation at our centre during a six-
year period from January 1991 to December 1996. We identified 26 patients who had
late acute rejection (LAR). The Medication Behaviour self-efficacy Scale is a 27-item
instrument depicting a variety of situations in which the patient might be required to
take their medication. The self-efficacy score was calculated by summing the scores
of all items divided by 27. Thus the self-efficacy scores range between 1 and 3; higher
score indicates greater self-efficacy. We modified the original scale to a 3-point
questionnaire as our pilot study showed that patients found it difficult to discriminate
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between 5 options. The LTMBS-scale was initially used to determine self-efficacy
and non-compliance with immunosuppressive medication in a group of 150 renal
transplant recipients (De Geest et aI.1995). The study hypothesized that there might
be a relationship between low rates of self-efficacy, knowledge of medication regime,
non-compliance and subsequent graft loss. Non-compliance with medication was
calculated at 22% with perceived lower scores of self-efficacy associated with items
8, 9 and 14 relating to physical (sexual impotence, brittle bones, facial spots and
excessive hair growth) side effects of immunosuppressive medications.
The LTMBS-scale has also been utilised in conjunction with electronic
tagging in a longitudinal study of 101 heart transplant recipients to evaluate sub-
clinical non-compliance with CyA over a three-month period. Patients were at an
average of three years after a kidney transplant (De Geest et al. 1998). The findings of
this study suggested that overall compliance was high, with a median medication
compliance of 99.4%. However, on a micro level, they identified three clusters of
patients as follows: excellent compliers (84%), minor sub-clinical non-compliers (7%)
and moderate sub-clinical non-compliers (9%) and showed a 1.19%, 14.28% and
22.22% incidence of LAR respectively in these three groups of patients. There was a
clear association between higher degree of non-compliance and LAR. A larger multi-
centre study is in progress to validate the LTMBS-scale as a predictive measurement
is indicated. We have recently initiated such a study in the US.
Our study is a variation on the above-mentioned studies, in that it was
conducted retrospectively amongst patients who had already undergone LAR after
successful cadaver kidney transplantation. This is in direct contrast to the prospective
studies described above and thereby contributes to the validity of the LTBMS-scale.
Further, our findings were utilised not only as a means to identify non-compliance,
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but also as a preface to supportive psychotherapeutic intervention amongst no
compliers. It was hoped that such intervention might serve to prevent graft loss or as a
means to detect and address non-compliance before receiving a further transplant
should these patients loose their transplant.
Acute rejection after renal transplantation results in reduced graft survival and it
is known that LAR is even more detrimental to graft survival. In our own study
(Joseph et al. 2001), we determined the impact ofLAR by analysing 687 consecutive
adult renal transplant recipients. All received CyA-based immunosuppression, from
1984-1996, with a median follow-up of 6.9 years. Details were abstracted from
clinical records, with emphasis on age, sex, co-morbid conditions, HLA matching,
rejection episodes and patient and graft survival. Patients were classified by the
presence and time to AR from the date of transplantation. Using those patients who
had no AR episodes (NAR) as a baseline, we determined the relative risk of graft
failure by time to rejection. The characteristics of patients who had no rejection, EAR
and LAR were compared. Compared to NAR, the risk of graft failure was higher for
those patients who suffered a rejection episode. A much higher risk of graft failure
was seen when the first rejection episode occurred after 90 days. Thus a period of 90
days was taken to separate EAR and LAR (relative risk of 3.06 and 5.27 compared to
NAR as baseline, p<O.OOI).Seventy-eight patients (11.4%) had LAR, 271 (39.4%)
had EAR and 338 (49.2%) had NAR. The mean age for each of these groups differed
(LAR 39.6 years, EAR 40.8 years compared to NAR 44 years, p<O.003). The 5-year
graft survival for those who had LAR was 45% and 10-year survival was 28%. HLA
mismatches were more frequent in those with EAR versus NAR (zero mismatches in
A: 36% vs. 24%, B: 35% vs. 23% and OR: 63% vs. 41%, p<0.003). There was no
difference in mismatching frequency between NAR and LAR. AR had a deleterious
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impact on graft survival, particularly if occurring after 90 days. AR episodes should
therefore be divided into early and late phases. In view of the very poor graft survival
associated with LAR, it is important to gain further insight in to the main etiological
factors. Those such as sub-optimal CyA blood levels and non-compliance with
medication should be further investigated with the aim of developing more effective
immunosuppressive regimens in order to reduce the incidence of LAR.
LTMBS questionnaire was mailed to 24 patients (14 women and 10 men),
with an explanatory letter; patients were requested to complete the questionnaire
anonymously (Baines, Joseph and Jindal 2002a). After two weeks, we telephoned
each patient to inquire whether he or she had completed the questionnaire. If the
response was negative, she encouraged patients to complete and return the
questionnaire. Summing up all the responses and dividing by 27 computed confidence
of each patient. The values range from I (least confident) to 3 (most confident). When
a comparison of clinical data was needed, t-test was used. Statistical significance was
assumed at a p value of 0.05. The mean values are expressed as mean +/- standard
deviation. For statistical analysis and construction of the graph, a software package
(SPSS 9, SPSS inc. Chicago) was used. Our results showed a definitive correlation
between LAR, and individual patient's perceived low rate of self-efficacy across a
variety of contextual or environmental situations. It was seen that patients were only
reasonably confident (mean score 2.17) in taking their medication in the above-
mentioned contexts. AU patients demonstrated significantly lower self-efficacy in
relationship to items 14, 20 and 21 (mean score 1.0), the items relating to physical and
psychological symptoms (brittle bones and generally feeling 'very ill') and
psychological symptoms (feeling 'sad') that affected their well-being. These
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symptoms were considered to be side effects of either the medications or a response to
the experience of chronic illness.
The majority of patients (10 women, 5 men) returned their completed
questionnaires before the two-week telephone reminder. However, the seven
questionnaires (4 women, 3 men) that were returned after the telephone reminder
demonstrated an even lower self-efficacy score (mean score 1.2). The second group of
patients demonstrated the same trends as with the first group of patient (who returned
their questionnaire without prompting).
Potential drawbacks of this study is the reliance of the LTMBS-scale on
patient self-report and the absence of controls, as means to rule out the influence of
the above-mentioned environmental, or situational variables and increase internal and
construct validity. However, it was our intention to develop this tool as a means of
identifying the presence, as opposed to the degree of, non-compliance amongst
patients who might benefit from supportive psychotherapeutic intervention.
Therefore, the disadvantages of self-report (potential for distortion in the patients
favour) and the use of the control group (as a baseline for intervention) in the
traditional sense might be of little use. This is particularly valid in the present climate
as heightened patient awareness and independent help seeking behaviour is making it
increasingly difficult to maintain a sterile control group in both the medical and social
sciences. In developing this work further, we propose to extend supportive
psychotherapeutic intervention to vulnerable patients. This strategy will enable us to
address inconsistent answers or contradictory responses in completing the
questionnaire. Responses to the questionnaire could be further analysed and modified
by cognitive behavioural therapy.
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(b) Formal counselling: A common means to address depression and anxiety in this
group of patients is to implement counselling and psychotherapy programs. The renal
and transplant centre at the University of Toronto, Canada, has successfully
implemented a comprehensive counselling and psychotherapy program aimed at
facilitating the adjustment of organ (liver, kidney, heart and lung) transplant patients,
while supporting them through psychosocial and psychiatric support. To support,
patients on dialysis and awaiting kidney transplants the 'While you are waiting'
psycho-educational group was formed which comprised of a support and educational
program. Group discussions involved living with a life threatening illness, preparing
to live versus preparing to die, and preparing for transplantation (Abbey and Farrow
1998). This program was aimed at relatively emotionally stable patients placing
emphasis upon education and support as opposed to systematic psychological
intervention.
(c) Effect of psychotherapy on emotional states after kidney transplantation: We
designed a prospective study using psychotherapeutic principles to understand and
intervene in emotional issues in adult recipients of first cadaver kidney transplants.
Forty-nine recipients of first cadaver kidney transplants were subjected to 12 sessions
(at weekly intervals) of psychotherapy within three months of receiving their
transplant. The BDI was utilised as a measure of change in emotional state, pre-
therapy, at 3, 6, 9 and 12 months. We used the BDI to study the efficacy of our trial
by an objective method (Baines, Joseph and Jindal 2002b).
Of the many instruments available, we choose the BDI; we were however,
concerned that this instrument might be considered overly simplistic. We found that
references to BDI during treatment sessions were much more positive as patients
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appeared to find regular completion of the questionnaire therapeutic in terms of
contemplating the cause behind any regression, stagnation, or progress and helping
them to focus on specific problems and solutions and encouraging.
A higher score on BDI was suggestive of psychological dysfunction. In the
first instance, data was analysed within a quantitative framework, by virtue of the
BDI. In the second instance, data was considered in terms of recurring themes
described by patients during psychotherapy and was analysed qualitatively. In the
third instance, both qualitative and qualitative data was considered in terms of
individual patient's ability to achieve some feeling of having implemented some
social, relational and vocational equilibrium into their everyday life. Recipients of live
kidneys, paediatric transplants and patients who received more than one transplant
were excluded, as emotional issues are different in this cohort of patients. All patients
have completed one year of follow up. There was significant improvement in the BDI
scores following therapy. The mean score was 26.3 ± 7.9 before and 20.5 ± 8.8 after
therapy (p=O.OOI);lowering of scores remained sustained at 12 months. Multivariate
analysis of age, gender, employment status, duration of dialysis and psychotherapy
given before transplantation did not affect the results of our study. Successful
resolution of these issues was associated with lower BDI scores and the re-definition
of normality in daily living after the transplant.
(d): Group versus individual psychotherapy: In general, group psychotherapy is more
cost effective than individual therapy. In this study, we have prospectively, in a
randomised trial, compared the efficacy of group versus individual psychotherapy in
recipients of first cadaver kidney transplants versus age and gender matched control
patients who did not receive therapy. Both individual and group psychotherapy aim to
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benefit the patient emotionally, socially and relationally to promote the understanding
of them. The therapist aims to facilitate personal growth through interpretation,
intervention and reflection in response to the stories, thoughts, hopes, and ambitions,
fears that patients bring to sessions. In both contexts, a satisfactory psychotherapeutic
alliance is an essential pre-requisite to effective outcome. In addition, in a group
situation, they will be expected to interact with other group members.
In the group situation, as opposed to individual psychotherapy, the therapist
needs to pay attention to both individual and group interaction. It is through group and
individual interaction that themes emerge which in tum facilitate progress of the
group. However, too much or indeed too little intervention on part of the therapist can
hinder or totally suppress progress of the group. During individual therapy, therapist
will be concerned to contrast, invite comparison, or match stories and recollections in
keeping with the patient's past or present experiences and hopes for the future. In the
group situation, therapist might use one patient's experience to encourage other group
members to contribute similar happenings or as an opportunity to compare or contrast
experiences between group members. Similarly, if members ignore, deviate, act in a
dismissive manner, fail to give proper consideration or avoid particular themes,
therapist will need to decide whether to draw this to the group's attention
immediately, in the future, or not at all (Abbey and Farrow (998).
In our study, groups were member-led, while the therapist remained 'with' the
group aiming to identify, understand, refine and develop, individual experiences and
build group themes. Group members were encouraged to raise whatever issues they
wished. In tum, we aimed to be responsive, interactive and emotionally supportive to
facilitate individual and group goals. Primary problems associated with ongoing
chronic illness such as low self-esteem, uncertainty regarding future, lost of time to
54
chronic illness and re-defining normality were incorporated into the goals of the
group. It soon became apparent that individual attempts to define normality in terms
of the pre-morbid past meant that they had difficulty constructing a daily routine.
Through sharing of common experiences we hoped to address interpersonal issues,
which might be obstructing the formation of a more satisfying existence.
Recipients of first cadaver renal transplants within three months of surgery
were randomised (using computer generated numbers to ensure even gender and age
distribution) into two groups, to receive a 12-week course of group or individual
psychotherapy. BDI was utilised as a measure of change in emotional state, pre-
therapy, at 3, 6, 9 and 12 months. A higher score on BDI was suggestive of
psychological dysfunction. Patients were treated using the same therapist and
theoretical model (Systemic Integrative Psychotherapy) in both the groups. Study was
based on the need for at least 80% statistical power to determine differences between
success rates. Thirty-seven patients served as control group, however, it should be
noted that these patients were recruited consequently after the first two groups were
recruited for logistic reasons, to enable us to obtain adequate numbers for group arm.
The study was done on the basis of an intention to treat principle. The data are
expressed as mean ± standard deviation. The comparisons of the means of the scores
at various time periods between the individual and group therapy groups were made
by the use of Mann-Whitney U test and one-way ANOVA test as appropriate. The
significance of the impact of therapy within each treatment arm was assessed by
Wilcoxon rank sum test. The individual parameters were assessed for their effect on
the final result with the help of multivariate analysis. All the significance was
calculated as two tailed and was measured at a level of s 0.05. A statistical software
package was used for the computations (SPSS 9, SPSS Inc., Chicago).
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Eighty-nine patients who had a cadaver kidney transplant were recruited in to
the study. They were randomly allocated in to the two study groups, 49 for individual
and 40 for group therapy. Of these, 82 patients completed 12 weeks of therapy (45
patients from the individual arm and 37 from the group therapy arm). Fifty-five
patients have so far completed one-year follow-up (33 in individual and 32 in the
group therapy); the rest did not complete one year as they moved away or did not
return their questionnaires. Thirty-seven age and sex-matched patients were recruited
as controls; two dropped out of the study at three months and four at six months
respectively. A higher percentage of patients who had been on more than three years
of dialysis were allocated for group therapy; otherwise, there was no significant
difference between the characteristics of the study groups in the two arms. Our
population in the West of Scotland is approximately 98% Caucasians; therefore all the
patients in our study happened to be Caucasians. All patients had received their first
cadaver transplant, as psychological issues with a second or third transplant are
different than those receiving their first transplant. We also excluded paediatric
recipients and those receiving living kidney transplants as emotional issues and graft
outcomes are different to patients receiving a cadaver kidney.
In both the treatment groups, there was significant improvement in the scores
following therapy. The mean score was 26.3 ± 7.9 before and 20.5 ± 8.8 after therapy
in the individual group (p=O.OO1). This was in comparison with a mean score of 29.8
± 3.9 before and 27.1 ± 3.9 after therapy for the group arm of the study (p=O.OI).
Improvement was more significant in the individual therapy arm compared to group
arm (p= 0.01). Lowering of scores remained sustained in both therapy arms. In the
control arm, mean score was 9.4 ± 5.4 before and 20.5 ± 5.5 at the end of first year
(p=0.005) suggesting significant worsening of BDI scores. Multivariate analysis of
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age of the population, gender, employment status, duration of dialysis (if in dialysis
for more than three years) and psychotherapy given before transplantation did not
affect the results.
The BDI has generally been considered as crude measurement that does not do
justice to the idiosyncrasies of treatment or of the patient. However, we wanted to
produce objective data, which could encourage other centers to embark on similar
projects using the BDI or other instruments, or even devise a specific instrument for
this purpose. Our study clearly shows that psychotherapy was effective in lowering
BDI score; this presumably will lead to improved QOL and adherence to medications.
The fact that patients in the control group started with a lower BDI score is an
interesting finding; it is known that patients not expecting to receive therapy will not
think too deeply into psychological issues that affect their lives.
Methodology using patient self-report has also been criticised as liable to
exaggeration and underplaying of problems in an attempt to please the therapist. A
scenario commonly referred to as the 'hello-goodbye' effect or socially desirable
responding. We concluded that both individual and group psychotherapy were
beneficial to recipients of first cadaver kidney transplants, however, individual
therapy was found to result in lower BDI scores versus group therapy; while patients
in the control group had significant worsening of scores.
(el Reconciling bereavement and loss of the imagined past: Loss has been used
interchangeably with bereavement and grief and is generally associated with death or
feelings of total desolation. These concepts have generally been considered within a
recognized time frame of social withdrawal and resolution (Kubler-Ross 1978; Arieti
and 8emporad 1978; Parkes 1996). Kubler-Ross (1978) interviewed over two
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hundred patients with terminal illness during her work on bereavement. She divided
bereavement into a five stage recognized time frame as follows: denial and isolation,
anger, bargaining, depression and finally acceptance. Arieti and Bemporad (1978)
referred to bereavement and grief as a form of 'unbearable sadness' in response to the
death of another person. They viewed bereavement as a series of 'sad reactions', which
involved 'searching' and 'impressioning' of the person that had been lost. The length of
the bereavement process was thought to vary with each individual, but resolution was
considered in keeping with adjustment or acceptance that the person was dead. Parkes
(1996) studied the bereavement process of sixty-six widows. Arieti and Bemporad
(1978) described the notion of 'searching' for the dead person as a direct response to
the death of their husbands. The gradual realisation of the futility of the search was
equated with detachment from the dead person and the resolution of grief.
Amongst kidney transplant patient's loss, grief and bereavement have been
associated with graft rejection (Streltzer, Moe, Yanagida and Siemsen 1983; Alleman
et al. 1994), the death of relatives (Alleman et al. 1994), the death of fellow patients
(Vamos 1997), the fear of death amongst renal transplant patients (Eisendrath 1969),
and the death of the unknown donor (Kemph 1967). Graft rejection and the resolution
of grief and rejection of a kidney have been considered in terms of facilitating the
grieving process to resolution, measured in terms of re-adjustment to dialysis
(Streltzer et al. 1983-1984). The death of relatives from kidney failure has prompted
the use of unit-based support groups to treat bereaved families after transplant
(Alleman et al. 1994). The impact of death of a fellow patient within a treatment unit
has been described by some studies in keeping with pathological grief reactions. The
findings have considered grief in relationship to psychosomatic symptoms, which in
tum were thought to be complicated by the existence of 'survivor guilt' (Vamos 1997).
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The fear of death amongst renal patients as a result of post-operative complications
has been equated with fear, anxiety, depression, and deterioration in the quality of
inter-personal relationships (Eisendrath 1969). Donor family support programs have
gained momentum in recent years and have not only offered support to families upon
the death of their relatives (Kemph 1967; Alexander and Sehgal 1998), but also
helped relieve the burden of survivor guilt upon recipients.
We propose that grief and bereavement in the post-transplant period needs to
be considered within a wider context of an imagined past and as an entity independent
of the other causes of bereavement and grief. Loss of the imagined past refers to a
past (complied of experiences, sensations and achievements) that patients consider
that they might have had, if they had not developed renal failure. Loss in this context
(post-transplant) is generated as individuals contemplate fantasies, aspirations and
ambitions that were never realised. Clinically, this is expressed during psychotherapy
as feelings of low self-esteem, indifference to peers, a life without purpose and
hesitancy regarding the future. Unlike feeling of bereavement and grief, loss is not
systematically resolved within a time frame and does not necessarily result in social
withdrawal. However, in common with bereavement and grief, feelings of loss
amongst post-transplant patients are in keeping with a change in identity and social
status. A change of identity and social status serve to generate expectation with
regards an improved quality of life amongst patients and their families. In tum, the
pressure of expectation can serve to generate stress and anxiety, particularly when a
kidney transplant was viewed by the family as a panacea for any negative or
ambivalent emotional states evoked during dialysis. Our observations are that such
clinical presentation may be best explored and resolved within a time sensitive
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framework such as Systemic Integrative Psychotherapy (Clarkson and Lapworth
1996).
During psychotherapy sessions, patients on dialysis often perceive life as
being medically, socially (relationships with family and friends), economically
(curtailed employment and subsequent debt) unpredictable, unstable and centred upon
survival and preservation of their family and self. Given these circumstances, patients
may develop symptomatic psychopathology such as depression, stress and anxiety
(Marrone 1998; Harris and Bifulco 1991). While pre-existing family relationships
may be of help to patients in resolving their difficulties, prolonged dialysis can put
relationships under enormous strain and affect their ability to provide ongoing support
for the duration of dialysis. The tradition of psychotherapy provides a significant,
supportive, unconditional attachment figure, within a responsive and secure
environment. Within this relationship, post-transplant patients can explore and
recover from emotional problems such as loss. As mentioned above, dialysis patients
demonstrate an acute sensitivity to time. That is, time lost to dialysis and time that
comprises their future. More specifically, Systemic Integrative Psychotherapy is
based upon the psychotherapist's need to identify patient's experiences over a past,
present and future time-span. Our findings suggest that this segmentation of time
during psychotherapy sessions helps patients comprehend their feelings of
paradoxical loss after kidney transplantation. Further, such philosophy lends itself
well to the reconciliation of disappointments and fantasies that comprise the imagined
past, sustenance of patients in the present and provides a baseline for future
development.
Our observations amongst kidney transplant patients suggest that while grief and
bereavement may be recalled amongst all three of the above-mentioned time-spans, it
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is most prominent in the patients (fantasy) imagined past. Therefore, patients become
hesitant and pessimistic regarding the future and they consider that any future that
they might have, will be conducted within an arena in which they are materialistically,
socially and economically disadvantaged, despite their kidney transplant. In summary,
the imagined past is an entity that was never actualised; the present struggles to be
meaningful and needs to be re-defined; while the future can only be actualised in the
face of seemingly insurmountable odds. This scenario manifests in the daily lives of
patients as social disintegration, isolation and subsequent feelings of grief and
bereavement.
We have proposed a new concept of loss of imagined past; this condition if
unresolved can lead to medical non-compliance and social isolation. This condition
must be differentiated from grief and bereavement that the patient may feel for the
donor and donor-family. In addition, this condition should not be confused with the
ongoing fear of graft rejection, graft loss, fear of death and side effects of drugs. In
working with transplant patients whose gift of life is somewhat paradoxical, we need
to identify the meaning and experience of loss of an imagined past for individual
patients, before it can be resolved.
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CONCLUSIONS
This thesis considers the concept of QOL within the context of patients on
renal dialysis and kidney transplantation. We suggest that QOL measurement tools
can be utilised to determine whether there is a relationship between QOL, medical
non-compliance and emotional states amongst this patient group. The research is
developed within a psycho-medical framework using Systemic Integrative
Psychotherapy. This facilitates the analysis and quantification of results favoured by
the medical profession while exploring the subtle nuances and emotional states
recalled by patients during the transplant process. The findings suggested that there is
a relationship between QOL, medical compliance and emotional states amongst
transplant patients. It is also suggested that emotional states are much more complex
than originaJIy thought; psychotherapy can effectively treat these states and
subsequently improve QOL. To improve compJiance and emotional states and hence
QOL after kidney transplantation, we have suggested a number of strategies based on
our research. These are patient empowerment, by asking them to fill up a specific
instrument CLTMBS), group or individual psychotherapy and helping them to come to
terms with their imagined past.
We propose that all recipients of organ transplants should be routinely
assessed for QOL by SF-36 or a disease-specific instrument, compliance by the
LTMBS-scale and psychological status by the BDI, BSI or the SCL-90-R. Adequate
funding should be provided for the additional expense in implementing a program of
assessment and intervention in appropriate cases. Over time, we may be able to
construct a universal instrument, which will capture these three components. The
merits of one instrument over the others will have to validated and accepted by the
transplant community.
62
The debate on the ideal instrument and whether if should be generic or
disease-specific continues. The Medical Outcomes Trust Boston, (www.outcomes-
trust.org) is a not for profit organisation dedicated to improving health and health care
by promoting the science of outcomes measurement, and the development, evaluation
and distribution of standardised, high quality instruments that measure health and the
outcomes of medical care. I am hopeful that efforts by organizations such as the
Medical Outcomes Trust, and the medical, sociology, psychology and behavioural
communities will result in a universally accepted QOL instrument. However, we must
bear in mind that measuring QOL will remain subjective and the development of
objective QOL instrument will be difficult; deriving an overall QOL score based on
different domains may be even more problematic.
The results of the questionnaires should be made available to the clinician
before consultation and additional time provided to discuss issues raised by the
patient. A recent study incorporating these instruments into outpatient consultation for
patients undergoing palliative chemotherapy was found to be useful to facilitate
discussion of QOL issues for both patients and their physicians (Detmar, Muller,
Schomagel and Wever 2002). We believe there is a pressing need for a 'Consensus
Conference' on QOL issues after organ transplantation. We hope to sensitise
transplant physicians to the many factors that can influence the 'goodness of life', a
person's happiness and the ability to function independently and to enjoy life (Parmet
2002).
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ABSTRACT
We performed a systematic review of the literature on medical noncompliance after
kidney transplantation in the cyclosporine era. We wished to define commonalities that may help
the clinician identify patients for early intervention. We found that patients who were at a higher
risk of noncompliance after kidney transplants were younger, female, unmarried and non-
Caucasians. Patients who were recipients ofliving transplants and were transplanted longer time
ago with a history of previous transplant were also at risk of noncompliance. We also found that
patients displaying emotional problems such as anxiety, hostility, depression, distress, lack of
coping and avoidant behaviors were also at risk of noncompliance after kidney transplantation.
2
INTRODUCTION
Compliance with medications after organ transplantation is emerging as a major health
care issue with implications for chronic rejection and graft loss. Patients who loose their grafts
due to noncompliance may be denied a second transplant, an area of considerable controversy and
debate. Furthermore, health care financing is assuming a central role in our society. Patients who
lose their transplants due to noncompliance will result in a significant drain on finances as these
patients are placed back on dialysis, a modality of treatment more expensive than a functioning
transplant (1-3).
Medical noncompliance is also important as it is estimated that over 25% of patients who
enter into clinical trials of immunosuppressive drugs may be noncompliant and hence influence
the results of these studies negatively. Noncompliance will also negatively affect a patient's
quality of life after transplantation and ultimately have detrimental results on society itself.
Patients who are on dialysis may also sutTer from a lack offull employment versus those patients
with a functioning transplant. Patients with a functioning transplant also have a significantly
longer life span versus patients who are on chronic dialysis (4-8).
A number of authors have studied various factors, which atTect medical compliance after
kidney transplantation. These include demographics, social and educational status, mental and
behavioral patterns. pre- and posttransplant symptoms and beliefs, and the characteristics of the
transplanted organ. A variety of validated instruments have been described to assess and in some
cases predict medical noncompliance after a kidney transplant. These methods include pill counts,
clinic attendance. drug levels and self-administered questionnaires. Each of these methods has
pitfalls and may not be equally applicable to all patients. A gold standard of assessing patients at
risk of noncompliance has not yet been validated.
Research to date concerning predictors and levels of medical noncompliance have been
3
difficult to interpret and the outcomes of center-specific studies may not be easy to apply in
clinical practice. We have applied meta-analytic techniques to the literature on medical
noncompliance after kidney transplantation to enable a consensus to be reached in this important
area. The aim of this study was to identify patients at risk for noncompliance after kidney
transplant. Further work is required to identify the best instrument to identify patients at risk of
medical noncompliance after a kidney transplant.
Our study is limited to patients receiving kidney transplants as this group forms the largest
cohort of patients receiving a solid organ transplant.
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METHODS
Searching: Two authors searched independently using the Medline followed by hand searching.
The most recent search was done in June of2001. The search included the terms: compliance,
non-compliance, medical compliance and kidney transplants, transplantation, organ
transplantation and medical compliance/non-compliance. Additional reports were identified from
the reference lists of key manuscripts and review articles. For the analysis of data, only peer-
reviewed articles in English language journals were considered. Only manuscripts in the
cyclosporine (CyA) era and involving adult recipients of kidney transplants were included (1-26).
Data extraction: This was done by two authors and checked for accuracy by a third author. Tables
of the collected data were prepared for analysis.
Validity assessment: None of the papers reported a randomized trial, the majority of the studies
were of a descriptive nature. The selected papers were prospective in which questionnaires were
given to recipients who already had functioning kidney transplants.
Manuscripts selected for analysis: Frazier et al. (1) sent detailed questionnaires to 500 recipients
of renal transplants at the University of Minnesota of which 49% were returned. They used a
variety of standardized instruments such as the Beck Depression Inventory (BDI), Brief
Symptom Inventory (BSI), Inventory of Social Supportive Behaviors (ISSB) and
Multidimensional Health Locus of Control (MHLC). They analyzed their data using multiple
regression. Siegal and Greenstein (3) prospectively sent questionnaires to 2500 patients in US
transplant centers of which 1402 returned, of which 22.4% reported some level of
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noncompliance with their medications after renal transplant. These patients were over 18 years of
age and were on CyA therapy and had a functioning transplant. In their study, noncompliance
was scaled from I (never forgot) to 8 (forget every day). For each variable, they calculated the
frequency, means, percentages and standard deviations and then logistic regression analyses were
used to identify predictors of noncompliance. Cluster analysis was used to identify groups of
noncompliant patients based on similarities with respect to variables identified by logistic
regression.
Raiz et al. (4) conducted a postal survey of 712 patients from the Ohio State University
Medical Center who were 18 years old and had a primary renal transplant for at least 12 months.
They used the Dillman's method for mailed surveys with analysis by multiple regression. Usable
data was obtained from 50% of the patients. Didlake et al. (5) from the University of Texas
Medical School at Houston, USA, performed a mail survey of295 patients who had received a
kidney transplant between 1980 and 1986 and were compared with 70 patients who had a
functioning transplant for at least 18 months. They defined noncompliance when the patients
presented with rejection episodes and were interviewed by 2 members of the transplant team and
the blood levels of CyA were sub-therapeutic. They analyzed the mean values of population
parameters using t-tests.
Schweizer et al. (6) performed a combination of retrospective and prospective analysis of
patients receiving kidney, liver and heart transplants at the Hartford Transplant Center, Hartford,
CT, USA. Their study was divided into retrospective chart review of260 patients between 1971
and 1984 and a prospective study of 196 patients between 1984 and 1987. They excluded
patients who lost their transplants in the first 3 months. The results were analyzed descriptively.
de Geest et al. (7) performed a descriptive cross-sectional study from the Catholic University of
Leuven, Belgium, on 150 recipients of kidney transplants who were at least 18 years old and one
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year after transplant. All but 2 patients were recruited and they were subjected to interviews and
psychometric tests. These authors used a variety of statistical analyses, which included Wilcoxon
rank sum test and Student's t test for independent variables. Logistic regression analysis was
applied to determine which variables or combinations of variables best predicted whether a
patient belonged to the compliant or noncompliant group.
Statistical issues: The major difficulty faced in reviewing the selected papers was that no two
manuscripts, presented data or analyses on the same outcomes in exactly the same manner. This
made impossible the conduct of a formal meta-analysis. In its place we have selected, as noted
above, a list of potential correlates with noncompliance and have tabulated for each manuscript
whether or not each potential variate was statistically significantly related to noncompliance.
Unfortunately some manuscripts reported only univariate associations, some only multivariate
associations and some both. The nature of these associations is indicated in the tabulations.
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RESULTS
We identified 26 manuscripts, which report on medical non-compliance after kidney
transplantation. Manuscripts 1-7 were considered to be suitable for inclusion in a review. To
analyze the different factors affecting medical noncompliance after kidney transplantation, we
selected the manuscript by Frazier et al. (1) as a template against which other studies were
analyzed. These factors were age, race, gender, martial status, income, employment, number of
transplants, emotional and mental issues (anxiety, hostility, depression, distress, stress, chance,
pain and coping). Other variables analyzed were infection, type of transplant (cadaver or living),
time since transplant, US born, education, diabetes, number of rejection episodes, dose of
prednisone, tremor, clinic attendance, distance, dialysis compliance and treated rejection
episodes. We also took into account the self-care agency score, self-efficacy score and situational
operational knowledge. The results of the analysis are given in the table.
Demographics: Patients who were older, married, male and had a higher income were
significantly more compliance with posttransplant medications in paper 1.The numbers were too
small for analysis in paper 2, while in paper 3; younger patients and white-collar employment
status were significant factors leading to noncompliance. In paper 4, Caucasians were more
compliant while in paper 5; race (Caucasians) and older age were associated with greater
compliance. In paper 6, blacks and younger recipients of kidney transplants were more
noncompliant. In paper 7, single or divorced patients were significantly more noncompliant
versus the married.
Transplant characteristics: In manuscript I, recipients with a history of previous transplant were
less compliant and those who had been transplanted a longer time ago were less compliant with
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follow regimen than were recipients who were more recently transplanted. In manuscript 3,
recipients who received a living transplant, had received a transplant long time ago, had no
history of diabetes and had a history of infection and were born outside the US were more
noncompliant. In manuscript 4, transplant type and other transplant related characteristics were
not important. In manuscripts 6 and 7, transplant characteristics were also not important. In
manuscript 5, no difference was seen in the type of transplant, duration of pre-transplant dialysis,
primary or re-transplant but the important differences in the noncompliant group were greater
then one rejection episode, prednisone dose, presence of tremor, greater distance from the clinic,
dialysis compliance and greater rejection episodes.
Psychosocial variables: Noncompliant patients were associated with greater emotional distress,
higher transplant-related stress and the belief that health outcomes were due to chance and the
use of avoidant coping strategies. Inmanuscript 4, noncompliant patients had greater anxiety. In
manuscript 7, compliant patients had a higher level of self -care agency, perceived self-efficacy of
long-term medication and higher situational-operational knowledge.
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DISCUSSION
The half-life of transplants has increased steadily, cadaver kidney transplants to 9-11
years and 15- I7 years for living transplants. This has meant that each center is following larger
numbers of transplants; current restrictions of health care financing does not allow each patient
to be seen by a qualified therapist to address psychosocial concerns. Some of these unresolved
concerns may lead to noncompliance with medications. It is estimated that 25% ofthis cohort of
patients may be noncompliant with medications; one-to-one therapy with a qualified therapist
would be prohibitively expensive. In this scenario, we suggest that specific groups of patients be
given special attention to increase the level of compliance such as younger, female, unmarried
and non-Caucasians, Other specific patients groups who may require special attention are
recipients of living transplants and were transplanted longer time ago with a history of previous
transplant. In addition, patients displaying emotional problems such as anxiety, hostility,
depression, distress, lack of coping and avoidant behaviors may be targeted for special attention
by qualified therapists to increase medical compliance.
Another approach to comprehending, and impacting upon compliance behaviors is
through the provision of psychotherapy services for renal patients. Our results show that there
was a significant improvement in BDI scores in patients who attended both group and individual
psychotherapy. However, individual psychotherapy is emerging as the most effective
intervention, particularly amongst patients who have been dialyzing for 3 years or more (27).
Even a successful implementation of group therapy program is difficult logistically in all
recipients of organ transplants. Perhaps, all patients may be included for a fixed period of time,
(perhaps 6 months) in group therapy. Further therapy may be limited to patients who are at high
risk of being noncompliant.
There are a large number of psychometric tests available for patients who are on long-
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term medications, such as recipients of kidney transplants. Authors have described the use of the
BDI, BSI, ISSB and MHLC to evaluate recipients of kidney transplants for assessment of
emotional problems, which may perhaps lead to medical noncompliance after kidney transplants.
These standardized instruments have been validated successfully in many psychological
disorders. However, their use in recipients of kidney transplantation are few and it is difficult to
recommend one test over others. Certainly, it is not possible to apply multiple instruments to all
recipients of kidney transplants, except as part of a research protocol. Based on our current study
and review of the literature, we are unable to recommend a single instrument, which may be
applicable universally to recipients of kidney transplants. We have used the BDI to evaluate
patients before and after therapy and found it to be useful in follow up (27). However, other
instruments may be equally valid forms of assessment. Indeed, such instruments are limited in
that they commonly measure emotional state at a given point in time, in other words, at the point
ofadministration. Furthermore, their ability to predict compliance is questionable and does not
further our understanding of noncompliant behaviors. Further research needs to be done in this
area.
It is not proven that a successful implementation of psychotherapy will definitely lead to
increased survival of a kidney transplant. However, the value of many forms of psychological
therapies has been proven in numerous psychiatric disorders. It follows as a corollary that
recipients of kidney transplants who suffer from emotional problems will benefit by the
implementation of psychological services in a transplant unit.
Another issue that needs to be considered is if addressing emotional problems leads to an
increased compliance with medications. Although we have shown that there is an improvement
in BDI scores after systematic integrative psychotherapy therapy, it is not known if this will lead
to improved compliance with medications. The lack of a standardized instrument for predicting
11
or measuring noncompliance will make it difficult to prove or disprove the latter point. A variety
of self-assessment questionnaires have been devised to investigate patient compliance with
medications, however, these are useful only after the patient has lost the transplant. In addition to
group therapy, we plan to assess the questionnaire devised by de Geest et al. (7) to profile patient
concerns regarding the side effects of medications. We will then be able to improve patients
understanding of medications and their potential side effects increasing patient empowerment
and hence compliance with medications.
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CONCLUSION
From our study, we conclude that patients who are at a higher risk of noncompliance after
kidney transplants were younger, female, unmarried and non-Caucasians. Patients who were
recipients of Iiving transplants and were transplanted longer time ago with a history of previous
transplant were also at risk of noncompliance. In general, all patients displaying emotional
problems such as anxiety, hostility, depression, distress, lack of coping and avoidant behaviors
were also at risk of noncompliance after kidney transplantation.
Pre-transplant screening should include psychosocial assessment using one or more ofthe
standardized instruments to identify patients at risk of noncompliance after transplant. Although
desirable, it is impossible to provide long-term counseling to all recipients of organ transplants.
A focussed approach directed towards patients at high risk of noncompliance would be more cost
effective. This strategy may decrease the number of kidney transplants lost due to noncompliance
with resultant economic benefit to the society (28).
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**+
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Stress +*
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**+
Coping (avoidance) +
Pain
(others)
Notes: • = also significant in multivariate analysis
•• = only reported for multivariate analysis
••• = only those with non-compliance leading to rejection vs complaints
. .
3.Infectlon •
Living related donor
Time since transplant
US born
Education
Diabetes·
5. > 1 rejection episodes,
Prednisone dose
Tremor
Clinic compliance
Distance
Dialysis compliance
Treated rejection episodes
7. Self-cast agency score
Self-efficacy score
Situational-operational
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ABSTRACT
Introduction: Recipients of kidney transplant have been shown to develop
emotional problems. These have been associated with medical non-compliance,
compromised quality of life and difficulty integrating the newly acquired
transplant into their sense of self. In general, group psychotherapy has been shown
to be more cost effective than individual therapy. We have compared the efficacy
of two modalities of therapy in recipients of kidney transplants versus control
patients who did not receive therapy.
Methodology: Recipients of first cadaver kidney transplants were randomized
into two groups, to receive a 12-week course of group or individual
psychotherapy. Control arm of the study comprised of37 consecutive patients
who had received a first cadaver kidney. Recipients of live kidney transplants and
patients who received more than one kidney transplant were excluded as these
patients have different emotional issues. The Beck Depression Inventory (BDI)
was utilized as a measure of change in emotional state, pre-therapy, at 3, 6, 9 and
12 months. A higher score on BDI was suggestive of psychological dysfunction.
Results: We recruited 89 recipients of first cadaver kidney transplants into the
study. They were randomly allocated in to the two study groups, 49 for individual
therapy and 40 for group therapy. Of these, 82 patients completed 12 weeks of
therapy (45 patients from the individual treatment arm and 37 from the group
therapy arm). Fifty-five patients completed one-year follow-up (33 in individual
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therapy and 32 in the group therapy). The mean score was 26.3 ± 7.9 before and
18.9 ± 9.0 after therapy in the individual treatment group (p=0.001). This was in
comparison with a mean score of 30.2 ± 3.8 before and 26.0 ± 4.2 after therapy for
the group therapy arm (p= 0.01). Improvement appeared to be more significant in
the individual therapy compared to group therapy (p= 0.01). Lowering of scores
was progressive and sustained (p=0.01). In the control arm, mean score was 9.4 ±
5.4 before and 20.5 ± 5.5 at the end of the first year (p==0.005)suggesting a
significant worsening of BDI scores. Multivariate analysis of age, gender,
employment status, duration of dialysis, etiology of kidney failure, diabetes
mellitus and psychotherapy received at any time before transplantation did not
affect results.
Conclusion: We conclude that both individual and group psychotherapy were
beneficial to our patients, however, individual therapy was found to result in
lower BDI scores versus group therapy at the end of treatment period.
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INTRODUCTION
Recipients of renal transplants have been shown to develop emotional
problems (1). Psychotherapy has been shown to be effective in addressing
developmental delay, coming to terms with the past and can be a catalyst for
change (2). In general, group psychotherapy is more cost effective than individual
therapy (3). In this study, we have prospectively, in a randomized trial, compared
the efficacy of group versus individual psychotherapy in recipients of first cadaver
kidney transplants versus age and gender matched control patients who did not
receive therapy.
We have described elsewhere along with step-by-step framework for
individual and group intervention and how emotional issues are more complex
and multi-faceted than previously suggested (4). We have shown that patients
have paradoxical depression and feelings of loss despite having received a long -
awaited kidney transplant. This loss has been considered in terms of time (along
with experiences and expectations) lost to chronic illness, in short, what might
have been. Therapeutically speaking, this loss is contemplated in terms of the
'imagined past'. The 'imagined past' does not exist beyond the bounds of the
patient's imagination and has not withstood the test of reality. Anxiety associated
with the uncertainty of renal failure and organ transplant often presents as panic
attacks. Patients in renal failure and after transplantation also have heightened
sense of their mortality, distorted body image and fear of rejection of the
transplanted organ.
The manner In which emotional problems impact upon compliance
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behavior, quality of life and the psychosocial integration of the newly acquired
organ adversely effect medical management and progression of the illness,
resulting in graft loss and even death has been well documented amongst
transplant patients (4, 5). The common thread running throughout the treatment of
these patients is the curtailment of lifesty Ie, pervasive sense of powerlessness and
loss associated with depressed mood. However, in contrast to other chronic
illnesses, little attempt has been made to mobilize psychosocial support for these
patients. Where such intervention does exist; it has been fragmented and
intermittent. However, our research suggests that individual and/or group
psychotherapy provides a forum to effectively address emotional issues in patients
receiving a kidney transplant which impacts positively upon compliance, quality
oflife and the integration of the new kidney (5).
Individual and group psychotherapy rely on the utilization of patient self-
report, a methodology criticized as being liable to exaggeration and underplaying
of problems in an attempt to please the therapist. A scenario commonly referred to
as the 'hello-goodbye' effect or socially desirable responding. We used the Beck
Depression Inventory (BDI) [6] to study the efficacy of our trial by an objective
method. Of the many instruments available, we choose the BDI; we were
however, concerned that this instrument might be considered overly simplistic.
We found that references to BDI during treatment sessions were considered
positively by patients who appeared to find regular completion of the
questionnaire therapeutic in terms of identifying milestones in treatment.
Our study showed that individual as opposed to group therapy was more
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effective in the treatment of emotional problems amongst recipients of renal
transplants. However, given the potential for bias pertaining to the single therapist
and cultural drift associated with single center studies, our study would need to be
repeated in a multi-center manner using a comparable theoretical orientation but
with different therapists.
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METHODS AND PATIENTS
Recipients of first cadaver renal transplants within 3 months of surgery
were randomized (using computer generated numbers to ensure even gender and
age distribution) into two groups, to receive a 12-week course of Systemic
Integrative group or individual psychotherapy. BDI was utilized as a measure of
change in emotional state, pre-therapy, at 3, 6, 9 and 12 months. A higher score on
BDI was suggestive of psychological dysfunction. Study was approved by the
local ethics committee. Patients were treated using the same therapist and
theoretical model (Systemic Integrative Psychotherapy) in both the groups. Study
was based on the need for at least 80% statistical power to determine differences
between success rates. Thirty-seven patients served as control group, however, it
should be noted that these patients were recruited consecutively after the first two
groups were recruited for logistic reasons, to enable us to obtain adequate
numbers for group arm. The BDI consists of21 groups of graded statements (the
higher the score the more negatively intense the feeling) relating to mood as
follows:
Question One
o I do not feel sad.
1 I feel sad.
2 I am sad all the time and can't snap out of it.
3 I am so sad and unhappy that I can't stand it.
Question Two
o I am not particularly encouraged about the future.
1 I feel discouraged about the future
2 I feel that I have nothing to look forward to.
3 I feel that the future is hopeless and that things cannot improve.
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BDI is a self-report questionnaire in which the patient has to read the statement
and circle a statement most accurately represented their feelings at the point of
assessment (before therapy began, at termination and 3, 6, 9, 12 months follow
up).
Statistics: The data are expressed as mean ± standard deviation. The comparisons
of the means of the scores at various time periods between the individual and
group therapy groups were made by the use of Mann- Whitney U test and one-way
ANOVA test as appropriate. The significance of the impact of therapy within each
treatment arm was assessed by Wilcoxon rank sum test. The individual parameters
were assessed for their effect on the final result with the help of multivariate
analysis. All the significance was calculated as two tailed and is measured at a
level of ~ 0.05. A statistical software package was used for the computations
(SPSS 9, SPSS Inc., Chicago).
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RESULTS
Eighty-nine patients who had a cadaver kidney transplant were recruited in
to the study. They were randomly allocated in to the two study groups, 49 for
individual and 40 for group therapy. Of these, 82 patients have completed 12
weeks of therapy (45 patients from the individual arm and 37 from the group
therapy arm). Fifty-five patients have completed one-year follow-up (33 in
individual and 32 in the group therapy); the rest did not complete one year as they
moved away or did not return their questionnaires. Thirty-seven, age and sex-
matched patients were recruited as controls; two dropped out of the study at three
months and four at six months respectively. Demographics of the study population
are shown in Table 1. A higher percentage of patients who had been on more than
three years of dialysis were allocated for group therapy; otherwise, there was no
significant difference between the characteristics of the study groups in the two
arms. Our population in the West of Scotland is approximately 98% Caucasians,
therefore all the patients in our study happened to be Caucasians. All patients had
received their first cadaver transplant as psychological issues with a second or
third transplant are different than those receiving their first transplant. We also
excluded pediatric recipients and those receiving living kidney transplants as
emotional issues and graft outcomes are different to patients receiving a cadaver
kidney.
Table 2 shows mean BDI scores in the three groups before treatment and
at various time points after therapy. In both treatment groups, there was significant
improvement in the scores following therapy. The mean score was 26.6 ± 7.9
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before and 18.9 ± 9.0 after therapy in the individual group (p=0. 001). This was in
comparison with a mean score of30.2 ± 3.8 before and 26.0 ± 4.2 after therapy for
the group arm of the study (p=0.01). Improvement was more significant in the
individual therapy arm compared to group arm (p= 0.01) [Table 1 and Figure 1].
Lowering of scores remained sustained (Table 2) in both therapy arms. In the
control arm, mean score was 9.4 ± 5.4 before and 20.5 ± 5.5 at the end of first
year (p=0.005) suggesting significant worsening of BDI scores (Figure 2).
Multivariate analysis of age of the population, gender, employment status,
duration of dialysis (if in dialysis for more than three years) and psychotherapy
given before transplantation did not affect the results (Table 3).
We also sought a correlation between clinical course and posttransplant
events in the three groups. There was no difference in the incidence of acute
rejection, wound infections or delayed graft function. Donor variables (age,
gender and cold ischemia time) did not differ between the groups. The meantime
for the development of first acute rejection following renal transplant was 68.8
days. The number of patients who developed early acute rejection was 19.2% in
individual, 18.6% in group therapy arm and 17% in control group. Delayed graft
function was diagnosed if the patient needed dialysis in the first week after
transplant. The incidence of delayed graft function was 30.6% in the individual
arm, 34% in the group arm and 30% in the control patients, which was not
significant.
Immunosuppression was similar in all the three groups. Patients received
cyclosporine-based therapy, with CellCept and prednisone. No induction with
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antibodies was carried out. Patients received 1 gram solumedrol in the OR,
followed by tapering doses so that all patients were on 20 mg/day at the end of 6
days, 15 mg/day at the end of 3 months and 5 mg/day at he end of a year. Acute
rejections were treated with pulsed steroids with a rapid taper.
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DISCUSSION
Negative pre-morbid personality traits are amplified during renal disease
and their relational aftermath is an issue amongst all patients. The development of
individual therapy has taken a predominantly psychoanalytical perspective to
address the transition from dialysis to transplantation and the subsequent
adaptation from illness to normal health (7). Cognitive-behavioral therapy has
been used to address stress, anxiety, depression and psychosocial adjustment to
illness (8). The findings were analyzed within the context of two intervening
variables, interpersonal support and control over their treatment to determine
compliance with the medical regime. The results suggested that cognitive
behavioral therapy had a positive effect on all patients for some of the above
issues, in particular for anxiety.
Transplant patients and their families have viewed short-term group
psychotherapy positively. Buchanan (9) described the primary benefits of group
therapy as being the opportunity to observe and support coping strategies, mutual
support and encouragement. However, short-term nature of the group and open
membership (ongoing or changing membership from week to week) was not
conducive to the exploration of relationship difficulties.
Group therapy amongst multi-organ transplant patients has been integrated
into the transplant program at the University of Toronto, Canada, as it was shown
to be cost effective in addressing emotional issues before and after transplantation
(10). Common recurring themes were those of infection, rejection, body image
changes and emotional problems such as delirium and depression. However, in
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our own comparative study of group and individual psychotherapy amongst post-
transplant patients, group therapy did not appear to be as effective as individual
therapy.
'Modified' group therapy has been has been utilized amongst patients
receiving dialysis (II). The group was initiated as a result of the recognition of the
stresses of ongoing dialysis and the need to address such problems if they were
not to become an obstacle to transplantation. The author commented on how he
had witnessed the progression of hemodialysis from an experimental to a
definitive treatment, which sustained life, but created emotional stresses regarding
body image, dependency on dialysis, resentment and conflict within families.
Other studies have attempted to utilize group therapy in dialysis units to combat
isolation and psychological denial and have been utilized as an effective
educational tool (12-14).
While individual and group therapy are different modalities, they have
common goals, namely to benefit the patient. This was achieved by encouraging
the patient to disclose hislher feelings and experiences and in conjunction with the
rest of the group, reflect and address them. The role of the therapist was to
facilitate such an exploration and assist in making sense of them. Patients tended
to present their feelings and experiences using a 'story' format; every patient had a
tale to tell and this was usually related in the group in terms of recalled
interactions with their social networks out side of the group and often replayed
between members of the group. Each member of the group brought with them a
set of expectations, fears and hopes of what they might achieve from treatment
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and how the therapist would facilitate such change. The most difficult dilemma
for most patients was that of wanting to change and yet reluctant to relinquish
familiar coping mechanisms, ways of thinking, behaving and their perception of
themselves.
However, we need to better understand why the control group reported less
emotional difficulties at the start of treatment, but were significantly more likely
to deteriorate over time, present for emotional crisis intervention and be admitted
for medical complications associated with non-compliance than their group or
individually treated counterparts. In order to do this we need to better understand
the psychological profile of the renal dialysis and transplant patient and to be
receptive to the utilization of a more pluralistic, combined quantitative-
quantitative methodological analysis of data. These findings appear to feed into
the current trend in the psychological sciences as to the need to establish which
patients benefit from which particular intervention over stipulated periods of time.
We suggest that given the above findings, any future research question to
determine the effectiveness of therapeutic intervention would need to be reframed.
That is, we should not ask which particular treatment intervention is the most
effective amongst this patient group, rather, which intervention is most likely to
permeate the 'boundary of inadmissibility'. This scenario was interpreted
qualitatively within the bounds of the study as the 'barrier of inadmissibility'. In
short, most transplant patients feel obliged to appear grateful for their transplant
and try to live up to the subsequent expectations that accompany it, while putting
their fears and uncertainties behind them. However. the availability of emotional
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intervention acts as a cue to patients to recognize emotional difficulties, in short, it
permeates the 'barrier of inadmissibility'. In our study, individual psychotherapy
appeared to be most effective at permeating the 'barrier of inadmissibility', while
group psychotherapy was less effective and the control group had virtually no
permeable qualities at all. However, for the control group patients, over time the
'barrier of inadmissibility' is permeated anyway by the difficulties of living the
fickle, uncertain and high maintenance life of a post-transplant patient. Hence,
there was deterioration in their emotional state over time.
Norms or expectations as to what constitutes acceptable and non-
acceptable behavior amongst group members might differ. Their cultural or family
background will largely reflect the manner in which many group members will
behave. The use of sarcasm or ridicule which, might to acceptable to some
patients, but not to others. Furthermore, there is always a danger in socially mixed
groups that better educated and more articulate patients might articulate their
thoughts, while the less educated feel intimidated. There is also a tendency
amongst the better educated to intellectualize issues which in a group situation can
lead to a 'debating style' being adopted. However, some members who might
remain silent for the most part in one group might be much more articulate in
another group where they feel either intellectually or socially superior or equal to
other group members. However, such individual trends tend to emerge over time
and are apparent during group interactions. The psychotherapist will become
aware of repeated patterns of interactions or silences, which will alert himlher to
alliances, allegiances and exclusion between group members. One way for a
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therapist faced with a fragmented group is to introduce some cohesion to the
group through the 'shared beliefs' or views, opinions, attitudes and shared reality
of group members.
The BDI has generally been considered as crude measurement that does
not do justice to the idiosyncrasies of the treatment process, the patient or
therapist for that matter (14). However, we wanted to produce objective data,
which could encourage other centers to embark on similar projects using the BDI
or other instruments, or even devise a specific instrument for this purpose. Our
study clearly shows that psychotherapy was effective in lowering BDI score; this
presumably will lead to improved quality of life and adherence to medications.
The fact that patients in the control group started with a lower BDI score is an
interesting finding; it is knO\\TI that patients not expecting to receive therapy will
not think too deeply into psychological issues that affect their lives.
We conclude that both individual and group psychotherapy were beneficial
to recipients of first cadaver kidney transplants, however, individual therapy was
found to result in lower BDI scores versus group therapy; while patients in the
control group had significant worsening of scores. Improving emotional states will
lead to improved quality of life and medical compliance and hence longevity of
the transplanted organ.
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LEGENDS
Table 1: Patient demographics
Table 2: Mean scores of BDI index at various time points (S.D. is given in
brackets).
Table 3: Results of the multivariate analysis (P-values for each parameter is
given).
Figure 1: Box plot showing the effect of therapy on actual BDI scores.
Fig 2: Box plot showing the difference in the BDI scores in the three groups
(control, individual treatment arm and group therapy arm) at three, six, nine
and twelve months following recruitment to the study compared to the BDI
scores before the recruitment. Group 0 denotes the control group, group 1
individual therapy and group 2, group therapy. The values represent the
difference from the initial score and hence the higher the difference, the higher
the effectiveness of the therapy.
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Table 1: Patient demographics
Control group Individual Therapy Group Therapy p-value
N=37 N=49 N=40
Age (years) 36.6 36.2 39.1
Mean± SD (± 11.9) (± 8.9) (± 11.1) 0.19
Female 15 27 17
Gender (40.5 %) (55%) (42%) 0.29
Male 22 22 23
(59.5 %) (45%) (58%)
Less than 3 13 35 18
Dialysis status years (35.1 %) (71%) (45%) 0.01
More than 24 14 22
3 years (64.9 %) (29%) (55%)
Previous 7 7 7
psychotherapy (18.9%) (14%) (18%) 0.45
Employed 12 9 7
Employment (32.4 %) (18%) (17%) 0.57
status Unemployed 25 40 33
(67.6 %) (82%) (83%)
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Table 2: Mean scores of BDI index at various time points (SD is given in
brackets)
Control group Individual Therapy Group Therapy
(n = 37) (n = 49) (n = 40)
Mean score Mean score Mean score
Before therapy 9.4 26.6 30.2
(±5.4) (±7.9) (±3.8)
At completion 12 weeks - 20.6 27.4
of therapy (±8.8) (±3.9)
3 months ILl 19.8 27.2
(±4.9) (±8.9) (±4.1)
After therapy 6 months 14.1 19.6 26.8
(±6.0) (±9.1) (±3.9)
9 months 17.3 19.2 26.5
(±3.7) (±8.8) C±4.0)
12 months 20.5 18.9 26.0
(±5.5) (±9.0) (±4.2)
p-value # 0.005 0.001 0.01
#: One-way ANOV A
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Table 3: Multivariate analysis of possible factors of influence on final results:
p-values
Individual therapy Group therapy
Age 0.55 0.57
Gender 0.58 0.84
Employment
status 0.13 0.38
Previous psycho
therapy 0.30 0.84
Duration of
dialysis 0.39 0.84
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Figure 1: Box plot showing the effect of individual vs. group therapy on
actual BDI scores
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Fig 2: Box plot showing the difference in the BDI scores in the three groups
(control, individual treatment arm and group therapy arm) at three, six, nine
and twelve months following recruitment to the study compared to the BDI
scores before the recruitment. Group 0 denotes the control group, group 1
individual therapy and group 2, the group therapy. The values represent the
difference from the initial score and hence the higher the difference, the higher
the effectiveness of the therapy.
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